
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152518F38AEEBA430518F3001BECB590.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Pediatric Transplantation">
<meta name="citation_title" content="Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden">
<meta name="citation_author" content="Oscar van der Have">
<meta name="citation_author_institution" content="The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author_institution" content="The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden">
<meta name="citation_author" content="Håkan Wåhlander">
<meta name="citation_author_institution" content="The Pediatric Heart Center, The Queen Silvia Children&#x27;s Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden">
<meta name="citation_author_institution" content="Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden">
<meta name="citation_author" content="Tove Hofbard">
<meta name="citation_author_institution" content="Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author" content="Dace Abele">
<meta name="citation_author_institution" content="Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden">
<meta name="citation_author_institution" content="Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden">
<meta name="citation_author" content="Maria Sjöborg Alpman">
<meta name="citation_author_institution" content="Pediatric Cardiology, Astrid Lindgren Children&#x27;s Hospital, Karolinska University Hospital, Stockholm, Sweden">
<meta name="citation_author_institution" content="Department of Women&#x27;s and Children&#x27;s Health, Karolinska Institute, Stockholm, Sweden">
<meta name="citation_author" content="Ilse Duus Weinreich">
<meta name="citation_author_institution" content="Scandiatransplant, Aarhus University Hospital, Aarhus, Denmark">
<meta name="citation_author" content="Jens Böhmer">
<meta name="citation_author_institution" content="Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden">
<meta name="citation_author_institution" content="Department of Pediatrics, Clinic Frankfurt‐Höchst, Frankfurt, Germany">
<meta name="citation_author_institution" content="Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden">
<meta name="citation_author" content="Johan Nilsson">
<meta name="citation_author_institution" content="Department of Translational Medicine, Thoracic Surgery and Bioinformatics, Lund University, Lund, Sweden">
<meta name="citation_author_institution" content="Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author" content="Jan Holgersson">
<meta name="citation_author_institution" content="Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden">
<meta name="citation_author_institution" content="Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden">
<meta name="citation_author" content="Ann‐Sofie Liedberg">
<meta name="citation_author_institution" content="Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author" content="Karin Tran‐Lundmark">
<meta name="citation_author_institution" content="The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author_institution" content="The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden">
<meta name="citation_author" content="Michal Odermarsky">
<meta name="citation_author_institution" content="The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden">
<meta name="citation_author_institution" content="Department of Clinical Science Lund, Lund University, Lund, Sweden">
<meta name="citation_publication_date" content="2025 Aug 17">
<meta name="citation_volume" content="29">
<meta name="citation_issue" content="6">
<meta name="citation_firstpage" content="e70154">
<meta name="citation_doi" content="10.1111/petr.70154">
<meta name="citation_pmid" content="40820386">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/pdf/PETR-29-e70154.pdf">
<meta name="description" content="The first 35 years of pediatric heart transplantation (pHTx) in Sweden were investigated to determine outcomes following listing and transplantation, investigate sub‐populations of recipients, and describe the presence of donor‐specific antibodies ...">
<meta name="og:title" content="Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The first 35 years of pediatric heart transplantation (pHTx) in Sweden were investigated to determine outcomes following listing and transplantation, investigate sub‐populations of recipients, and describe the presence of donor‐specific antibodies ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12358703">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/petr.70154"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/PETR-29-e70154.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12358703%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12358703/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12358703/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/petr.70154" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Pediatr Transplant</button></div>. 2025 Aug 17;29(6):e70154. doi: <a href="https://doi.org/10.1111/petr.70154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/petr.70154</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Pediatr%20Transplant%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pediatr%20Transplant%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Pediatr%20Transplant%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Pediatr%20Transplant%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Have%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Oscar van der Have</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Oscar van der Have</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Have%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Oscar van der Have</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A5hlander%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Håkan Wåhlander</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Håkan Wåhlander</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>The Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A5hlander%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Håkan Wåhlander</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofbard%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Tove Hofbard</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Tove Hofbard</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hofbard%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tove Hofbard</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abele%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Dace Abele</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Dace Abele</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div class="p">
<sup>
<sup>7</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Abele%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dace Abele</span></a>
</div>
</div>
<sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alpman%20MS%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Maria Sjöborg Alpman</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Maria Sjöborg Alpman</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Pediatric Cardiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alpman%20MS%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Sjöborg Alpman</span></a>
</div>
</div>
<sup>8,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weinreich%20ID%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ilse Duus Weinreich</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ilse Duus Weinreich</span></h3>
<div class="p">
<sup>
<sup>10</sup>
</sup>Scandiatransplant, Aarhus University Hospital, Aarhus, Denmark</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Weinreich%20ID%22%5BAuthor%5D" class="usa-link"><span class="name western">Ilse Duus Weinreich</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%B6hmer%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jens Böhmer</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jens Böhmer</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div class="p">
<sup>
<sup>11</sup>
</sup>Department of Pediatrics, Clinic Frankfurt‐Höchst, Frankfurt, Germany</div>
<div class="p">
<sup>
<sup>12</sup>
</sup>Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22B%C3%B6hmer%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jens Böhmer</span></a>
</div>
</div>
<sup>4,</sup><sup>11,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nilsson%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Johan Nilsson</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Johan Nilsson</span></h3>
<div class="p">
<sup>
<sup>13</sup>
</sup>Department of Translational Medicine, Thoracic Surgery and Bioinformatics, Lund University, Lund, Sweden</div>
<div class="p">
<sup>
<sup>14</sup>
</sup>Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nilsson%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Johan Nilsson</span></a>
</div>
</div>
<sup>13,</sup><sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Holgersson%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jan Holgersson</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jan Holgersson</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div class="p">
<sup>
<sup>7</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Holgersson%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jan Holgersson</span></a>
</div>
</div>
<sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liedberg%20AS%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Ann‐Sofie Liedberg</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Ann‐Sofie Liedberg</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liedberg%20AS%22%5BAuthor%5D" class="usa-link"><span class="name western">Ann‐Sofie Liedberg</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%E2%80%90Lundmark%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Karin Tran‐Lundmark</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Karin Tran‐Lundmark</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tran%E2%80%90Lundmark%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Karin Tran‐Lundmark</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Odermarsky%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Michal Odermarsky</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Michal Odermarsky</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden</div>
<div class="p">
<sup>
<sup>15</sup>
</sup>Department of Clinical Science Lund, Lund University, Lund, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Odermarsky%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michal Odermarsky</span></a>
</div>
</div>
<sup>1,</sup><sup>15</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="petr70154-aff-0001">
<sup>
<sup>1</sup>
</sup>The Pediatric Heart Center, Skåne University Hospital, Lund, Sweden</div>
<div id="petr70154-aff-0002">
<sup>
<sup>2</sup>
</sup>The Department of Experimental Medical Science and the Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden</div>
<div id="petr70154-aff-0003">
<sup>
<sup>3</sup>
</sup>The Pediatric Heart Center, The Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div id="petr70154-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div id="petr70154-aff-0005">
<sup>
<sup>5</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden</div>
<div id="petr70154-aff-0006">
<sup>
<sup>6</sup>
</sup>Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden</div>
<div id="petr70154-aff-0007">
<sup>
<sup>7</sup>
</sup>Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div id="petr70154-aff-0008">
<sup>
<sup>8</sup>
</sup>Pediatric Cardiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden</div>
<div id="petr70154-aff-0009">
<sup>
<sup>9</sup>
</sup>Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden</div>
<div id="petr70154-aff-0010">
<sup>
<sup>10</sup>
</sup>Scandiatransplant, Aarhus University Hospital, Aarhus, Denmark</div>
<div id="petr70154-aff-0011">
<sup>
<sup>11</sup>
</sup>Department of Pediatrics, Clinic Frankfurt‐Höchst, Frankfurt, Germany</div>
<div id="petr70154-aff-0012">
<sup>
<sup>12</sup>
</sup>Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden</div>
<div id="petr70154-aff-0013">
<sup>
<sup>13</sup>
</sup>Department of Translational Medicine, Thoracic Surgery and Bioinformatics, Lund University, Lund, Sweden</div>
<div id="petr70154-aff-0014">
<sup>
<sup>14</sup>
</sup>Department of Cardiothoracic and Vascular Surgery, Skåne University Hospital, Lund, Sweden</div>
<div id="petr70154-aff-0015">
<sup>
<sup>15</sup>
</sup>Department of Clinical Science Lund, Lund University, Lund, Sweden</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Oscar van der Have (<span>oscar.van_der_have@med.lu.se</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 7; Received 2025 Apr 4; Accepted 2025 Jul 29; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Pediatric Transplantation</em> published by Wiley Periodicals LLC.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12358703  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40820386/" class="usa-link">40820386</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="petr70154-sec-0001"><h3 class="pmc_sec_title">Background</h3>
<p>The first 35 years of pediatric heart transplantation (pHTx) in Sweden were investigated to determine outcomes following listing and transplantation, investigate sub‐populations of recipients, and describe the presence of donor‐specific antibodies (DSA) in a contemporary cohort.</p></section><section id="petr70154-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>Swedish children &lt; 18 years, listed from 1/1/1989 to 31/12/2023, were included. The cohort was split based on the era of transplantation (ERA I: 1989–2008, ERA II: 2009–2023).</p></section><section id="petr70154-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>A total of 254 children were listed and 185 (72.8%) reached pHTx, with no loss to follow‐up. Waiting list duration was 62 days and increased over time, while mortality on the waiting list decreased (30.5% in ERA I, 8.8% in ERA II). Congenital heart disease was the etiology of heart failure in 36.2% of recipients, including 24.9% with univentricular physiology. The frequency of ABO‐incompatible transplantations was 9.3% and 8.0% were considered to be at high immunological risk pre‐pHTx due to pre‐formed HLA‐antibodies with mean fluorescence intensity ≥ 5000. Ventricular assist device (VAD) was used in 26.9% of recipients. Long‐term survival was not affected by age, heart failure etiology, the use of pre‐transplant VAD, or elevated baseline indexed pulmonary vascular resistance. Era of transplantation was a determinant of listing, but not post‐pHTx outcome. Survival at 1‐, 10‐, and 30‐year follow‐up was 94.5%, 79.4%, and 57.1%, respectively. Of the total <em>de novo</em> DSA burden, 45.9% were HLA‐DQ‐type specific. Re‐transplantation was performed in 5.9% of recipients.</p></section><section id="petr70154-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>A high quality of care has been achieved in Sweden, despite modest pHTx numbers, in cooperation with the Scandiatransplant organization.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> donor‐specific antibodies, end‐stage heart failure, era‐dependent analysis, pediatric heart transplantation, pulmonary vascular resistance</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>The first 35 years of pediatric heart transplantation (pHTx) in Sweden were investigated to determine outcomes following listing and transplantation, investigate sub‐populations of recipients, and describe the presence of donor‐specific antibodies (DSA) in a contemporary cohort. A high quality of care has been achieved in Sweden, despite modest pHTx numbers, in cooperation with the Scandiatransplant organization.</p>
<section class="bt xbox font-sm" id="petr70154-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/cdfad095df78/PETR-29-e70154-g006.jpg" loading="lazy" id="jats-graphic-1" height="219" width="390" alt="graphic file with name PETR-29-e70154-g006.jpg"></p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="petr70154-dl-0001">
<dt id="petr70154-li-0001">ABOi</dt>
<dd id="petr70154-li-0002"><p>ABO‐incompatible transplantation</p></dd>
<dt id="petr70154-li-0003">AVT</dt>
<dd id="petr70154-li-0004"><p>acute vasoreactivity testing</p></dd>
<dt id="petr70154-li-0005">C1q</dt>
<dd id="petr70154-li-0006"><p>Complement component 1q</p></dd>
<dt id="petr70154-li-0007">CAV</dt>
<dd id="petr70154-li-0008"><p>coronary allograft vasculopathy</p></dd>
<dt id="petr70154-li-0009">CDC</dt>
<dd id="petr70154-li-0010"><p>complement‐dependent cytotoxicity</p></dd>
<dt id="petr70154-li-0011">CHD</dt>
<dd id="petr70154-li-0012"><p>congenital heart disease</p></dd>
<dt id="petr70154-li-0013">CM</dt>
<dd id="petr70154-li-0014"><p>cardiomyopathy</p></dd>
<dt id="petr70154-li-0015">DBD</dt>
<dd id="petr70154-li-0016"><p>donation after brain death</p></dd>
<dt id="petr70154-li-0017">DCD</dt>
<dd id="petr70154-li-0018"><p>donation after circulatory death</p></dd>
<dt id="petr70154-li-0019">DCM</dt>
<dd id="petr70154-li-0020"><p>dilated cardiomyopathy</p></dd>
<dt id="petr70154-li-0021">dnDSA</dt>
<dd id="petr70154-li-0022"><p>
<em>de novo</em> donor‐specific antibodies</p></dd>
<dt id="petr70154-li-0023">ECMO</dt>
<dd id="petr70154-li-0024"><p>extracorporeal membrane oxygenation</p></dd>
<dt id="petr70154-li-0025">HCM</dt>
<dd id="petr70154-li-0026"><p>hypertrophic cardiomyopathy</p></dd>
<dt id="petr70154-li-0027">HLA</dt>
<dd id="petr70154-li-0028"><p>human leukocyte antigen</p></dd>
<dt id="petr70154-li-0029">MCS</dt>
<dd id="petr70154-li-0030"><p>mechanical circulatory support</p></dd>
<dt id="petr70154-li-0031">PH</dt>
<dd id="petr70154-li-0032"><p>pulmonary hypertension</p></dd>
<dt id="petr70154-li-0033">pHTx</dt>
<dd id="petr70154-li-0034"><p>pediatric heart transplantation</p></dd>
<dt id="petr70154-li-0035">PRA</dt>
<dd id="petr70154-li-0036"><p>panel‐reactive antibodies</p></dd>
<dt id="petr70154-li-0037">PVRi</dt>
<dd id="petr70154-li-0038"><p>indexed pulmonary vascular resistance</p></dd>
<dt id="petr70154-li-0039">RCM</dt>
<dd id="petr70154-li-0040"><p>restrictive cardiomyopathy</p></dd>
<dt id="petr70154-li-0041">Re‐pHTx</dt>
<dd id="petr70154-li-0042"><p>pediatric heart re‐transplantation</p></dd>
<dt id="petr70154-li-0043">UVH</dt>
<dd id="petr70154-li-0044"><p>univentricular heart</p></dd>
<dt id="petr70154-li-0045">VAD</dt>
<dd id="petr70154-li-0046"><p>ventricular assist device</p></dd>
</dl>
<section id="petr70154-sec-0005"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Since its inception in 1989, pediatric heart transplantation (pHTx) in Sweden has been centralized to Queen Silvia Children's Hospital in Gothenburg and Skåne University Hospital in Lund, which together provide for ~10.5 million inhabitants. Following the first two decades (1989–2009), a waiting list mortality of 31% and a post‐transplant 10‐year survival of 76% were reported by Gilljam et al. [<a href="#petr70154-bib-0001" class="usa-link" aria-describedby="petr70154-bib-0001">1</a>]. Sweden is part of Scandiatransplant, an organ allocation organization that coordinates all listing and solid organ exchange in the Nordic countries (Norway, Denmark, Finland, Iceland and Sweden) and Estonia [<a href="#petr70154-bib-0002" class="usa-link" aria-describedby="petr70154-bib-0002">2</a>], covering the needs of ~30 million inhabitants. The impact of short‐ and long‐term mechanical circulatory support (MCS), pulmonary hypertension (PH) and the presence of donor‐specific antibodies (DSA) on pHTx outcomes in Sweden remains to be determined.</p>
<p>The use of MCS as a bridge to pHTx, especially in small children and infants, has increased worldwide in the contemporary era [<a href="#petr70154-bib-0003" class="usa-link" aria-describedby="petr70154-bib-0003">3</a>, <a href="#petr70154-bib-0004" class="usa-link" aria-describedby="petr70154-bib-0004">4</a>, <a href="#petr70154-bib-0005" class="usa-link" aria-describedby="petr70154-bib-0005">5</a>]. Data on post‐transplant outcomes remain scarce [<a href="#petr70154-bib-0006" class="usa-link" aria-describedby="petr70154-bib-0006">6</a>, <a href="#petr70154-bib-0007" class="usa-link" aria-describedby="petr70154-bib-0007">7</a>]. Pediatric ventricular assist device (VAD) and ECMO programs involve great risks [<a href="#petr70154-bib-0008" class="usa-link" aria-describedby="petr70154-bib-0008">8</a>, <a href="#petr70154-bib-0009" class="usa-link" aria-describedby="petr70154-bib-0009">9</a>] and should be closely monitored [<a href="#petr70154-bib-0009" class="usa-link" aria-describedby="petr70154-bib-0009">9</a>, <a href="#petr70154-bib-0010" class="usa-link" aria-describedby="petr70154-bib-0010">10</a>, <a href="#petr70154-bib-0011" class="usa-link" aria-describedby="petr70154-bib-0011">11</a>].</p>
<p>PH in children with end‐stage heart failure is most often caused by pulmonary venous congestion secondary to high left atrial pressure; thus, post‐capillary PH [<a href="#petr70154-bib-0012" class="usa-link" aria-describedby="petr70154-bib-0012">12</a>]. If left untreated, pulmonary arterial vasoconstriction and remodeling ensue [<a href="#petr70154-bib-0013" class="usa-link" aria-describedby="petr70154-bib-0013">13</a>, <a href="#petr70154-bib-0014" class="usa-link" aria-describedby="petr70154-bib-0014">14</a>], causing combined pre‐ and post‐capillary PH with elevated pulmonary vascular resistance index (PVRi). This may preclude children from pHTx, although data on the importance of elevated PVRi for long‐term outcomes following pHTx is ambiguous [<a href="#petr70154-bib-0012" class="usa-link" aria-describedby="petr70154-bib-0012">12</a>]. Practice for hemodynamic evaluation and acute vasoreactivity testing (AVT), as well as clinical management of elevated PVRi, displays significant heterogeneity in this patient group [<a href="#petr70154-bib-0015" class="usa-link" aria-describedby="petr70154-bib-0015">15</a>].</p>
<p>
<em>De novo</em> DSA (dnDSA) has been detected in as many as 33%–43% of children following pHTx [<a href="#petr70154-bib-0016" class="usa-link" aria-describedby="petr70154-bib-0016">16</a>] and are increasingly being linked to antibody‐mediated rejection (AMR), coronary allograft vasculopathy (CAV) and poor long‐term outcomes in both the pediatric and adult populations [<a href="#petr70154-bib-0016" class="usa-link" aria-describedby="petr70154-bib-0016">16</a>, <a href="#petr70154-bib-0017" class="usa-link" aria-describedby="petr70154-bib-0017">17</a>]. Interestingly, Dipchand et al. postulated a B‐cell memory response to be the cause of a significant amount of early detected dnDSA in children [<a href="#petr70154-bib-0017" class="usa-link" aria-describedby="petr70154-bib-0017">17</a>], suggesting pre‐pHTx sensitizing events despite the absence of significant levels of HLA‐antibodies pre‐pHTx.</p>
<p>The current study aimed to describe donor and recipient populations, and outcomes, as well as pHTx management during the first 35 years of pHTx practice, 1989–2023, in Sweden. Specific emphasis was put on exploring the impact of elevated PVRi, pre‐transplant short‐ and long‐term MCS, elevated immunological risk, univentricular physiology, and ABO‐incompatible (ABOi) transplant on post‐transplant survival. Additionally, we sought to describe the development of high‐risk dnDSA in a contemporary Swedish cohort of pHTx recipients.</p></section><section id="petr70154-sec-0006"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="petr70154-sec-0007"><h3 class="pmc_sec_title">2.1. Study Design</h3>
<p>This was a nationwide, multicenter, retrospective observational cohort study approved by the Swedish Ethical Review Authority (Dnr 2020‐02140, Dnr 2023‐05036‐02 and Dnr 2024‐05951‐02) and conducted in accordance with the International Society for Heart and Lung Transplantation ethical statement. The requirement of informed consent was waived due to the retrospective nature of the study. Reporting of this study conforms to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) [<a href="#petr70154-bib-0018" class="usa-link" aria-describedby="petr70154-bib-0018">18</a>] and Reporting of Studies Conducted Using Observational Routinely Collected Health Data (RECORD) guidelines [<a href="#petr70154-bib-0019" class="usa-link" aria-describedby="petr70154-bib-0019">19</a>].</p></section><section id="petr70154-sec-0008"><h3 class="pmc_sec_title">2.2. Study Population and Data Sources</h3>
<p>All children &lt; 18 years residing in Sweden that were listed for pHTx, including simultaneous listing for other organs, between January 1st 1989 and December 31st 2023 were identified through the Scandiatransplant registry (Aarhus University Hospital, Aarhus, Denmark). Children listed for combined heart‐lung transplantation were excluded from this study, as they were considered to have significantly different clinical courses. Data at waiting list entry, as well as recipient and donor characteristics at both listing and transplantation, were acquired from the Scandiatransplant registry. When registry records were incomplete, complementary data were collected from the patients' medical records. Immunological data was obtained from HLA Fusion (One Lambda/Thermo Fisher Scientific), ProSang (Omda AS) and Scandiatransplant. All follow‐up data until December 31st of 2023 was included. Immunological data on HLA type and typing on the allelic level of resolution, dnDSA mean fluorescence intensity (MFI) values, complement‐dependent cytotoxicity (CDC) screening against HLA well‐types, healthy donors, and crossmatch tests (CDC and flow cytometry) were available and collected for patients transplanted from January 1st 2009 until December 31st 2023. Population data were collected from Statistics Sweden.</p></section><section id="petr70154-sec-0009"><h3 class="pmc_sec_title">2.3. Definitions</h3>
<p>Patients were grouped by era of transplantation, based on the availability of detailed immunological data, generating two eras: January 1st 1989–December 31st 2008 (ERA I, 20 years, no detailed immunological data available), January 1st 2009–December 31st 2023 (ERA II, 15 years, detailed immunological data available). A minimum duration of 1 day was considered for both waiting list time and post‐transplant survival. The total number of days on the waiting list was accounted for. Patients that deteriorated and died shortly after being taken off the list were counted as deceased in the waiting list mortality analysis. The end of follow‐up, and thus the censor date, was December 31st 2023. Patients withdrawn from the list due to improvement or deterioration, but later re‐listed and transplanted, were included only once in the waiting list and post‐transplant analyses. The second listing occasion, preceding pHTx or death, was used for defining the start of waiting list duration and for analysis of patient listing characteristics and outcomes in these patients. Patients listed for pediatric heart re‐transplantation (re‐pHTx) and re‐pHTx‐recipients were excluded from the main analyses and are commented on separately.</p></section><section id="petr70154-sec-0010"><h3 class="pmc_sec_title">2.4. Immunological Methods and Analyses</h3>
<p>Details on HLA‐typing and matching, HLA‐detection and identification, virtual panel reactive antibody (vPRA) calculations, and crossmatch test are all available in Data <a href="#petr70154-supitem-0001" class="usa-link">S1</a>. Antibody levels were expressed as MFI and were rounded to two value figures due to the semi‐quantitative nature of the analysis. MFI &gt; 1000 was considered positive for any given HLA antibody [<a href="#petr70154-bib-0020" class="usa-link" aria-describedby="petr70154-bib-0020">20</a>]. An HLA antibody was considered persistent if it displayed &gt; 1 positive test with at least 6 months in between individual tests, whereas isolated positive findings were considered transient. Patients displaying any preformed HLA‐antibodies with MFI &gt; 1000 were considered to have an elevated immunological risk, while patients displaying any preformed HLA‐antibodies with MFI &gt; 5000 were considered to have a high immunological risk. Patients with only HLA‐antibodies with MFI &lt; 1000 were considered to have normal immunological risk. One vPRA value was calculated for all preformed HLA‐antibodies with MFI &gt; 1000. In addition, for all preformed HLA‐antibodies with MFI &gt; 5000, the suggested MFI limit for high immunological risk with an increased risk for acute AMR [<a href="#petr70154-bib-0021" class="usa-link" aria-describedby="petr70154-bib-0021">21</a>], a second vPRA percentage was calculated. For HLA‐A, HLA‐B, HLA‐DR, and HLA‐DQ DSA, both <em>de novo</em> and preformed, antibodies were considered clinically significant if MFI &gt; 1000. For HLA‐Cw, HLA‐DP, and HLA‐DR3/4/5, both <em>de novo</em> and preformed, antibodies were considered clinically significant if MFI &gt; 2000. For HLA mismatch analysis, HLA‐A, B, C, DR, and DQ were included. Whilst on the waiting list, antibody screening was performed every 3 months. Follow‐up after detection of DSA‐antibodies was guided individually, depending on clinical suspicion of rejection.</p></section><section id="petr70154-sec-0011"><h3 class="pmc_sec_title">2.5. Statistical Analysis</h3>
<p>Normality distribution was assessed with histograms, normality tests (Kolmogorov–Smirnov and Shapiro–Wilk), Q–Q plots, and skewness. Variables are described using frequencies and percentages (categorical variables) and mean and standard deviation (SD) or medians and interquartile range (IQR) or range (continuous variables). Continuous variables were compared by independent samples <em>t</em> test or Mann–Whitney test (2 groups) and one‐way ANOVA or Kruskal‐Wallis test (&gt; 2 groups). Categorical variables were compared by Fisher's exact test (2 groups) or Pearson <em>χ</em>
<sup>2</sup> test (&gt; 2 groups). All patients contributed time (in days) on the waiting list until removal from the list (death, pHTx or withdrawal) or the censor date, whichever came first. Additionally, transplanted patients contributed follow‐up time from the date of pHTx until the date of death or the censor date. Survival rates for all‐cause mortality were estimated using the Kaplan–Meier method, and the log‐rank test was used to compare differences between the curves. Cox proportional hazard regression was used with and without stepwise multivariable adjustment to estimate hazard ratio (HR) and 95% confidence interval (CI) for the association between era of transplantation and waiting list mortality or post‐transplant survival, with ERA I as the reference time period. Variables were selected a priori based on clinical experience. Mortality on the waiting list was adjusted for age, sex, blood group, and diagnosis. Post‐transplant survival was adjusted for recipient and donor sex, recipient and donor age groups, recipient and donor weight mismatch ratio at transplant, diagnosis, urgency, pre‐transplant kidney function (estimated or measured glomerular filtration rate [GFR]), cold ischemia time, cytomegalovirus (CMV) mismatch, ABOi transplant, and pretransplant treatment with a VAD or extracorporeal membrane oxygenation (ECMO). Simple linear regression analysis was performed to investigate the relationship between pre‐ or post‐AVT PVRi and post‐pHTx survival time. A 2‐sided <em>p</em> value of &lt; 0.05 was considered statistically significant. Analyses were performed using Stata software (StataSE, version 17.0, StataCorp).</p></section></section><section id="petr70154-sec-0012"><h2 class="pmc_sec_title">3. Results</h2>
<section id="petr70154-sec-0013"><h3 class="pmc_sec_title">3.1. Study Population, Recipient and Donor Characteristics</h3>
<p>A total of 272 children were listed for pHTx during the study period. Eighteen children listed for combined heart‐lung transplantation were excluded, leaving 254 children to be included in the study. Three patients on the waiting list were transplanted abroad but had all follow‐up visits in Sweden. Characteristics at listing and transplantation are outlined in Tables <a href="#petr70154-tbl-0001" class="usa-link">1</a> and <a href="#petr70154-tbl-0002" class="usa-link">2</a>, respectively. Figure <a href="#petr70154-fig-0001" class="usa-link">1</a> contains a flow chart of the included study population.</p>
<section class="tw xbox font-sm" id="petr70154-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Patient characteristics at wait list entry.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th align="left" colspan="5" valign="bottom" rowspan="1">Listing characteristics</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ERA I (<em>n</em> = 118)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ERA II (<em>n</em> = 136)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Total (<em>n</em> = 254)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age at listing, years</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.7 (IQR 0.8–14.0, range 2 days–17.6 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.4 (IQR 2.1–14.3, range 18 days–17.9 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8.3 (IQR 1.6–14.2, range 2 days–17.9 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.422</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt; 1 year</td>
<td align="center" valign="top" rowspan="1" colspan="1">31 (26.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (16.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (20.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.079</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1–10 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">39 (33.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60 (44.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">99 (39.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">11–17 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">48 (40.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">54 (39.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102 (40.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Sex, female</td>
<td align="center" valign="top" rowspan="1" colspan="1">52 (44.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 (45.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">114 (44.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.808</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">ABO</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 115)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 136)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 251)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">56 (48.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">58 (42.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">114 (45.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.177</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">B</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (6.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (13.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">25 (10.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AB</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (5.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (7.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">O</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (35.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52 (38.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">93 (37.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diagnosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 118)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 136)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 254)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHD</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (44.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48 (35.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">101 (39.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.118<a href="#petr70154-note-0004" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">UVH</td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (28.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38 (27.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">71 (28.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.996</td>
</tr>
<tr>
<td align="left" style="padding-left:20%" valign="top" rowspan="1" colspan="1">HLHS</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (11.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (15.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (13.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.409</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CM</td>
<td align="center" valign="top" rowspan="1" colspan="1">65 (55.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">88 (64.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">153 (60.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.118<a href="#petr70154-note-0004" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">DCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">56 (47.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64 (47.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">120 (47.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.075</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">HCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (3.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (5.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (4.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">RCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (4.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (12.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Listing outcome</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 118)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 136)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(<em>n</em> = 254)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Death</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (30.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (8.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48 (18.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">pHTx</td>
<td align="center" valign="top" rowspan="1" colspan="1">72 (61.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">113 (83.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">185 (72.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Withdrawal<a href="#petr70154-note-0005" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (8.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (5.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (7.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">On list</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (2.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (1.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wait list duration, days<a href="#petr70154-note-0006" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (IQR 12–115, range 1–527)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79 (IQR 20–188, range 1–816)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 (IQR 13–154, range 1–816)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.005</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/petr70154-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="petr70154-note-0002"><p>
<em>Note:</em> ERA I: 1989–2008, ERA II: 2009–2023. Variables are described using frequencies and percentages for categorical variables and median with interquartile range for continuous variables. Continuous variables were compared by Kruskal‐Wallis test. Binary and categorical variables were compared by Pearson <em>χ</em>
<sup>2</sup> test.</p></div>
<div class="fn" id="petr70154-note-0003"><p>Abbreviations: CHD, congenital heart disease; CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; HLHS, hypoplastic left heart syndrome; pHTx, pediatric heart transplantation; RCM, restrictive cardiomyopathy; UVH, univentricular heart.</p></div>
<div class="fn" id="petr70154-note-0004">
<sup>
<sup>a</sup>
</sup><p class="display-inline">
<em>p</em>‐value for the comparison between CHD and CM.</p>
</div>
<div class="fn" id="petr70154-note-0005">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Three patients in ERA II were withdrawn from the list, but later relisted and transplanted. Aiming to study patients, not listing occasion, outcomes and survival, we opted to present the listing occasion terminated with HTx in this table. Adjusting the frequencies to account for the primary listing occasion instead, the withdrawal frequency in ERA II and the total time period would have been 11 (8.1%) and 21 (8.3%) respectively, with <em>p</em> &lt; 0.001 in the comparison between ERA I and ERA II.</p>
</div>
<div class="fn" id="petr70154-note-0006">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Three patients in ERA II were still on the waiting list at the censor date (2023‐12‐31) and thus only contributed wait list duration until this date.</p>
</div>
</div></section><section class="tw xbox font-sm" id="petr70154-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Recipient and donor characteristics at pediatric heart transplant.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000"><th align="left" colspan="5" valign="bottom" rowspan="1">Recipient and donor characteristics</th></tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ERA I (<em>n</em> = 72)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">ERA II (<em>n</em> = 113)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Total (<em>n</em> = 185)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Recipient age at transplant, years</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.7 (IQR 5.5–15.7, range 0.1–17.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.4 (IQR 4.2–14.9, range 25 days‐18.7 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.6 (IQR 4.6–15.0, range 25 days‐18.7 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.469</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">&lt; 1 year</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (13.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (7.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (9.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.164</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">1–10 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (29.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (39.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">66 (35.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.164</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">11–17 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (56.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60 (53.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">101 (54.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.164</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Donor age, years</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (8–37), <em>n</em> = 48</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (6–37)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (7–37), <em>n</em> = 161</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.816</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Recipient sex, female</td>
<td align="center" valign="top" rowspan="1" colspan="1">31 (43.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">50 (44.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">81 (43.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.881</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Donor sex, female</td>
<td align="center" valign="top" rowspan="1" colspan="1">36 (50.7%), <em>n</em> = 71</td>
<td align="center" valign="top" rowspan="1" colspan="1">61 (54.5%), <em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">97 (53.0%), <em>n</em> = 183</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.651</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Recipient ABO</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 72</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 113</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 185</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.123</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (55.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">48 (42.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">88 (47.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">B</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (5.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (15.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (11.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AB</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (8.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (6.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (7.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">O</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (30.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (36.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">63 (34.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Donor ABO</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 70</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 113</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 183</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.487</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">A</td>
<td align="center" valign="top" rowspan="1" colspan="1">31 (44.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (38.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">75 (41.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">B</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (7.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (10.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AB</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">O</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (48.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (46.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">87 (47.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">ABOi</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 70</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 113</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 183</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Major<a href="#petr70154-note-0009" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (2.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (9.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.060</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Minor<a href="#petr70154-note-0010" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (24.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (20.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (21.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.060</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Positive crossmatch</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%), <em>n</em> = 63</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (4.5%), <em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">5<a href="#petr70154-note-0011" class="usa-link">
<sup>c</sup>
</a> (2.9%), <em>n</em> = 175</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.089</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Donor/recipient weight ratio<a href="#petr70154-note-0012" class="usa-link">
<sup>d</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4 (IQR 1.1–1.7, range 0.9–3.3), <em>n</em> = 67</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4 (IQR 1.1–1.8, range 0.7–3.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.4 (IQR 1.1–1.8, range 0.7–3.6), <em>n</em> = 180</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.984</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Diagnosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 72</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 113</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 185</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CHD</td>
<td align="center" valign="top" rowspan="1" colspan="1">27 (37.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (35.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67 (36.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.772</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">UVH</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (19.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 (28.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">46 (24.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.173</td>
</tr>
<tr>
<td align="left" style="padding-left:20%" valign="top" rowspan="1" colspan="1">HLHS</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (9.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (14.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (12.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.373</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CM</td>
<td align="center" valign="top" rowspan="1" colspan="1">45 (62.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">73 (64.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">118 (63.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.772</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">DCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (56.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52 (46.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">93 (50.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.085</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">HCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (5.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (3.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">RCM</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (13.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (9.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wait list duration, days</td>
<td align="center" valign="top" rowspan="1" colspan="1">58 (IQR 12.5–120, range 1–527)</td>
<td align="center" valign="top" rowspan="1" colspan="1">78 (IQR 16–180, range 1–816)</td>
<td align="center" valign="top" rowspan="1" colspan="1">67 (IQR 13–163, range 1–816)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.161</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Highly urgent at transplant</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 (37.1%), <em>n</em> = 70</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (30.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60 (32.8%), <em>n</em> = 183</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.336</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">CMV<sup>+</sup>
</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Recipient</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (57.8%), <em>n</em> = 71</td>
<td align="center" valign="top" rowspan="1" colspan="1">52 (46.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">93 (50.5%), <em>n</em> = 184</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.132</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Donor</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (60.3%), <em>n</em> = 58</td>
<td align="center" valign="top" rowspan="1" colspan="1">63 (57.3%), <em>n</em> = 110</td>
<td align="center" valign="top" rowspan="1" colspan="1">98 (58.3%), <em>n</em> = 168</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.744</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">EBV<sup>+</sup>
</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Recipient</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (59.7%), <em>n</em> = 67</td>
<td align="center" valign="top" rowspan="1" colspan="1">59 (52.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">99 (55.0%), <em>n</em> = 180</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.355</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Donor</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (73.1%), <em>n</em> = 26</td>
<td align="center" valign="top" rowspan="1" colspan="1">81 (77.1%), <em>n</em> = 105</td>
<td align="center" valign="top" rowspan="1" colspan="1">100 (76.3%), <em>n</em> = 131</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.797</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">Recipient preoperative status</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pacemaker</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (27.5%), <em>n</em> = 69</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (18.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40 (22.0%), <em>n</em> = 182</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.197</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">VAD</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (17.4%), <em>n</em> = 69</td>
<td align="center" valign="top" rowspan="1" colspan="1">37 (32.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49 (26.9%), <em>n</em> = 182</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.026</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ECMO</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.5%), <em>n</em> = 67</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (7.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (5.6%), <em>n</em> = 180</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.093</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">eGFR (mL/min/1.73m<sup>2</sup>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">79 (IQR 70–90.5, range 51–137), <em>n</em> = 56</td>
<td align="center" valign="top" rowspan="1" colspan="1">86 (IQR 73–106, range 29–191), <em>n</em> = 97</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 (IQR 71–97, range 29–191), <em>n</em> = 153</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.069</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PVRi, baseline (WU·m<sup>2</sup>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.7 (IQR 2.2–6.3, range 1.4–13.0), <em>n</em> = 36</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (IQR 1.7–4.8, range 0.4–19.0), <em>n</em> = 63</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.3 (IQR 2–5.40, range 0.4–19.0), <em>n</em> = 99</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.067</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PVRi, post‐AVT (WU·m<sup>2</sup>)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.6 (IQR 2.6–4.3, range 1.5–5.1), <em>n</em> = 13</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.0 (IQR 2.0–4.5, range 0.6–7.9), <em>n</em> = 17</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.1 (IQR 2.3–4.5, range 0.6–7.9), <em>n</em> = 30</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.901</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cold ischemia time (minutes)</td>
<td align="center" valign="top" rowspan="1" colspan="1">199 ± 60, <em>n</em> = 70</td>
<td align="center" valign="top" rowspan="1" colspan="1">199 ± 65, <em>n</em> = 110</td>
<td align="center" valign="top" rowspan="1" colspan="1">199 ± 63, <em>n</em> = 180</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.962</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">Recipient postoperative status</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pacemaker</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.7%), <em>n</em> = 64</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (2.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (3.4%), <em>n</em> = 177</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.669</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">VAD</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.6%), <em>n</em> = 66</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (1.7%), <em>n</em> = 179</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.049</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ECMO</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.8%), <em>n</em> = 63</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (11.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (9.1%), <em>n</em> = 176</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.176</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Dialysis</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.7%), <em>n</em> = 64</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (6.3%), <em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (5.7%), <em>n</em> = 176</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.749</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression, induction</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 69</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 181</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ATG</td>
<td align="center" valign="top" rowspan="1" colspan="1">66 (95.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">76 (67.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">142 (78.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Basiliximab</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (29.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (18.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Daclizumab</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (2.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (2.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Steroids</td>
<td align="center" valign="top" rowspan="1" colspan="1">64 (92.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">112 (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">176 (97.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.007</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other<a href="#petr70154-note-0013" class="usa-link">
<sup>e</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (0.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.000</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression, discharge</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 69</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 181</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Azathioprin</td>
<td align="center" valign="top" rowspan="1" colspan="1">53 (76.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (7.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61 (33.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MMF</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (26.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">111 (99.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">129 (71.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cyclosporin</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (63.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">44 (24.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tacrolimus</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (27.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">112 (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">131 (72.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression, last follow‐up</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 67</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 112</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 179</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Prednisone</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (26.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (14.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34 (19.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.049</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Azathioprin</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (16.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (1.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (7.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MMF</td>
<td align="center" valign="top" rowspan="1" colspan="1">41 (61.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">92 (82.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">133 (74.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.003</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cyclosporin</td>
<td align="center" valign="top" rowspan="1" colspan="1">21 (31.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (8.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (16.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Tacrolimus</td>
<td align="center" valign="top" rowspan="1" colspan="1">39 (58.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">102 (91.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">141 (78.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Everolimus</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (16.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35 (31.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">46 (25.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.034</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sirolimus</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (6.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (1.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (3.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.199</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/petr70154-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="petr70154-note-0007"><p>
<em>Note:</em> ERA I: 1989–2008, ERA II: 2009–2023. Variables are described using frequencies and percentages for categorical variables and mean and standard deviation or medians and interquartile range for continuous variables. Continuous variables were compared by one‐way ANOVA or Kruskal‐Wallis test. Binary and categorical variables were compared by Pearson <em>χ</em>
<sup>2</sup> test.</p></div>
<div class="fn" id="petr70154-note-0008"><p>Abbreviations: ABOi, ABO‐incompatible transplantation; ATG, anti‐thymocyte globulin; CHD, congenital heart disease; CMV<sup>+</sup>, cytomegalovirus positive; DCM, dilated cardiomyopathy; EBV<sup>+</sup>, Ebstein‐Barr virus positive; ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration rate; HCM, hypertrophic cardiomyopathy; MMF, mycophenolate mofetil; PVRi, pulmonary vascular resistance index; RCM, restrictive cardiomyopathy; VAD, ventricular assist device; WU·m<sup>2</sup>, Woods units.</p></div>
<div class="fn" id="petr70154-note-0009">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Major ABOi: A/B/AB → O or AB → A/B or A → B or B → A.</p>
</div>
<div class="fn" id="petr70154-note-0010">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Minor ABOi: O → A/B/AB or A/B → AB.</p>
</div>
<div class="fn" id="petr70154-note-0011">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Out of 5 positive crossmatches, only 2 were CDC positive following DTT. The remainder were negative on CDC‐test, but positive when performing flow cytometry crossmatch testing.</p>
</div>
<div class="fn" id="petr70154-note-0012">
<sup>
<sup>d</sup>
</sup><p class="display-inline">Ratio calculated as [donor weight]/[recipient weight].</p>
</div>
<div class="fn" id="petr70154-note-0013">
<sup>
<sup>e</sup>
</sup><p class="display-inline">One patient received rituximab, bortezomib and plasmapheresis as additional induction treatment at the time of transplantation.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="petr70154-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/22ac308ed903/PETR-29-e70154-g003.jpg" loading="lazy" id="jats-graphic-3" height="636" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Study flow chart. pHTx, pediatric heart transplantation; re‐pHTx, pediatric heart re‐transplantation. *One child was taken of the waiting list due to clinical deterioration and died shortly after de‐listing (within 30 days) and is thus counted towards waiting list mortality in all analyses.</p></figcaption></figure></section><section id="petr70154-sec-0014"><h3 class="pmc_sec_title">3.2. Waiting List Course of Events and Mortality</h3>
<p>The cumulative incidence of listing for pHTx increased from 3.05 per million in ERA I to 4.40 per million in children &lt; 18 years of age in Sweden (44% increase), and the incidence over the study period was 3.65 per million. A median number of 7 (IQR 4.5–11, range 1–15) children were listed annually during the study period. The median annual number of children listed during ERA I was 5 (IQR 3.8–11, range 1–11), and 9 (IQR 7.5–12, range 3–15) during ERA II. Kaplan–Meier survival estimates describing survival probability within the first 500 days following listing are shown in Figure <a href="#petr70154-fig-0002" class="usa-link">2</a>. Waiting list mortality rates for the entire cohort at 30, 100, and 365 days were 9.7% (95% CI 6.4–14.5), 18.6% (95% CI 13.6–25.2) and 36.4% (95% CI 27.1–47.8) respectively (Figure <a href="#petr70154-fig-0002" class="usa-link">2A</a>). The 30‐day waiting list mortality rate was 16.0% (95% CI 10.1–24.9) for ERA I and 4.2% (95% CI 1.8–9.8) for ERA II, while the 1‐year waiting list mortality was 56.1% (95% CI 41.2–72.0) and 20.2% (95% CI 10.7–36.4) for the respective eras (Figure <a href="#petr70154-fig-0002" class="usa-link">2B</a>). Stepwise adjustment for covariates using Cox proportional hazard modeling displayed a significantly lower risk for waiting list mortality during ERA II compared to ERA I (HR 0.21, Table <a href="#petr70154-tbl-0003" class="usa-link">3</a>). The full model is available as Table <a href="#petr70154-supitem-0001" class="usa-link">S1</a>.</p>
<figure class="fig xbox font-sm" id="petr70154-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/b8ba4f92653a/PETR-29-e70154-g002.jpg" loading="lazy" id="jats-graphic-5" height="508" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Survival probability during the first 500 days of listing in Sweden, 1989–2023. ERA I: 1989–2008, ERA II: 2009–2023. Kaplan–Meier estimated survival for the first 500 days on the waiting list for the full cohort (A) and stratified by era of transplantation (B), age group at listing (C) and diagnosis at listing (D). CHD, congenital heart disease; CM, cardiomyopathy.</p></figcaption></figure><section class="tw xbox font-sm" id="petr70154-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Mortality on waiting list and post‐transplant survival by era of transplantation.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">HR</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="5" valign="top" rowspan="1">Wait list mortality</td></tr>
<tr>
<td align="left" style="padding-left:10%" rowspan="3" valign="top" colspan="1">ERA II (1989–2008) vs. ERA I (2009–2023)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Era unadjusted</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.21</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.11–0.41</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Era‐adjusted for sex and age group</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.20</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.10–0.38</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Era adjusted for 4 covariates<a href="#petr70154-note-0016" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.21</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.10–0.42</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">Post‐transplant survival</td></tr>
<tr>
<td align="left" style="padding-left:10%" rowspan="4" valign="top" colspan="1">ERA II (1989–2008) vs. ERA I (2009–2023)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Era unadjusted</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.52</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.25–1.05</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.068</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Era‐adjusted for recipient and donor sex and age group</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.44</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.20–0.95</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.037</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Era adjusted for 7 covariates<a href="#petr70154-note-0017" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.46</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.21–1.04</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.063</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Era adjusted for 13 covariates<a href="#petr70154-note-0018" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.46</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.15–1.43</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.182</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/petr70154-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="petr70154-note-0014"><p>
<em>Note:</em> Multivariable Cox proportional hazard regression for wait list and post‐transplant survival analyzed by ERA II (2009–2023) versus ERA I (1989–2008) of transplantation.</p></div>
<div class="fn" id="petr70154-note-0015"><p>Abbreviations: ABOi, ABO‐incompatible transplant; CI, confidence interval; ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration rate; HR, hazard ratio; VAD, ventricular assist device.</p></div>
<div class="fn" id="petr70154-note-0016">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Sex, age, group of diagnosis (CHD vs. CM) and blood group (ABO).</p>
</div>
<div class="fn" id="petr70154-note-0017">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Recipient and donor sex, recipient and donor age groups, group of diagnosis, donor‐recipient weight mismatch ratio, and urgency at transplant. Variables were selected a priori based on clinical experience.</p>
</div>
<div class="fn" id="petr70154-note-0018">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Recipient and donor sex, recipient and donor age groups, group of diagnosis, donor‐recipient weight mismatch ratio and urgency at transplant, eGFR, cold ischemic time, ABOi, CMV mismatch, preoperative VAD and preoperative ECMO. Variables were selected a priori based on clinical experience.</p>
</div>
</div></section></section><section id="petr70154-sec-0015"><h3 class="pmc_sec_title">3.3. Transplantation and Donors</h3>
<p>The cumulative incidence of pHTx increased from 1.86 per million in ERA I to 3.65 per million in ERA II (96% increase) in children &lt; 18 years of age. The incidence over the entire study period was 2.66 per million. A median of 5 (IQR 3–7, range 0–13) children were transplanted annually: 3.5 (IQR 1.8–5, range 0–9) during ERA I and 7.0 (IQR 6–9, range 4–13) during ERA II. Induction and maintenance immunosuppressive regimens displayed significant variations over time (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>). Two concomitant liver transplantations were performed, both during ERA II. No concomitant kidney transplantations were performed. Donation after circulatory death (DCD) was legalized in Sweden in 2020; but so far, no children have undergone pHTx with DCD donors.</p></section><section id="petr70154-sec-0016"><h3 class="pmc_sec_title">3.4. Post‐Transplant Survival</h3>
<p>No patient was lost to follow‐up. Median follow‐up time was 8.6 years (IQR 3.2–15.0 years, range 1 day—34.1 years); 16.6 years for ERA I (IQR 9.8–24.1, range 1 day—34.1 years) and 5.6 years for ERA II (IQR 2.2–9.4 years, range 4 days—15.0 years). The 30‐day mortality was 2.2% (<em>n</em> = 4) over the entire study period, with rates of 2.8% (<em>n</em> = 2) during ERA I and 1.8% (<em>n</em> = 2) during ERA II. The 1‐ and 5‐year post‐transplant survival during the study period was 94.5% (95% CI 90.0–97.0) and 87.0% (95% CI 80.7–91.4), respectively. Kaplan–Meier estimates for post‐transplant survival are shown in Figure <a href="#petr70154-fig-0003" class="usa-link">3</a>. Post‐transplant 10‐, 20‐, and 30‐year survival for the entire cohort was 79.4% (95% CI 71.6–85.2), 63.0% (95% CI 52.1–72.2) and 57.1% (95% CI 44.3–68.1), respectively (Figure <a href="#petr70154-fig-0003" class="usa-link">3A</a>). The 10‐year survival rate was 73.6% (95% CI 61.8–82.3) in ERA I and 85.3% (95% CI 74.3–91.8) in ERA II (Figure <a href="#petr70154-fig-0003" class="usa-link">3B</a>). In addition, survival post‐pHTx did not differ between age groups (Figure <a href="#petr70154-fig-0003" class="usa-link">3C</a>, log‐rank <em>p</em> = 0.360) and was not associated with the etiology of heart failure (Figure <a href="#petr70154-fig-0003" class="usa-link">3D</a>, log‐rank <em>p</em> = 0.816). After stepwise adjustment for covariates using Cox proportional hazard modeling, ERA II did not entail significantly lower risk for post‐transplant mortality compared to ERA I (HR 0.46, Table <a href="#petr70154-tbl-0003" class="usa-link">3</a>). The full model is available in Table <a href="#petr70154-supitem-0001" class="usa-link">S2</a>. Causes of post‐transplant mortality (<em>n</em> = 44) are summarized in Table <a href="#petr70154-supitem-0001" class="usa-link">S3</a>.</p>
<figure class="fig xbox font-sm" id="petr70154-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/5a85202041db/PETR-29-e70154-g001.jpg" loading="lazy" id="jats-graphic-7" height="506" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Post‐transplant survival for pediatric heart transplant recipients in Sweden, 1989–2023. ERA I: 1989–2008, ERA II: 2009–2023. Kaplan–Meier estimated post‐transplant survival for the full cohort (A) and stratified by era of transplantation (B) age group at listing (C) and diagnosis at transplant (D). CHD, congenital heart disease; CM, cardiomyopathy.</p></figcaption></figure></section><section id="petr70154-sec-0017"><h3 class="pmc_sec_title">3.5. Re‐Listing and Re‐Transplantation</h3>
<p>Seven patients aged &lt; 18 years (3.8% of all pHTx recipients) were listed for re‐pHTx (two from ERA I and five from ERA II). The median age at re‐listing was 12.9 years (IQR 12.5–13.2, range 0.80–13.4). Six of the re‐listed patients reached re‐pHTx (two from ERA I and four from ERA II), with a median time of 62 days (IQR 36–106, range 1–166) on the waiting list. Re‐pHTx took place after a median of 3.4 years (IQR 0.6–10.0, range 1 day–10.9 years) following primary pHTx. When including re‐transplants in adult age, a total number of 11 patients (5.9% of all pHTx recipients) underwent heart re‐transplantation during the study period. One patient received a third graft in adulthood.</p></section><section id="petr70154-sec-0018"><h3 class="pmc_sec_title">3.6. Specific Populations of Listed and Transplanted Children in Sweden</h3>
<section id="petr70154-sec-0019"><h4 class="pmc_sec_title">3.6.1. Univentricular Physiology and Sub‐Types of CMs
</h4>
<p>The fractions of listed children with UVH and HLHS remained constant over time; however, there was an increase in the percentage of children with UVH and HLHS that reached pHTx over time (Tables <a href="#petr70154-tbl-0001" class="usa-link">1</a> and <a href="#petr70154-tbl-0002" class="usa-link">2</a>). Listing and transplantation of patients with restrictive CM (RCM) increased over time (Tables <a href="#petr70154-tbl-0001" class="usa-link">1</a> and <a href="#petr70154-tbl-0002" class="usa-link">2</a>). Mortality on the waiting list was not higher for UVH (Figure <a href="#petr70154-supitem-0001" class="usa-link">S1A</a>, log rank <em>p</em> = 0.828) compared to non‐UVH CHD. Children with HLHS did not show worse waitlist survival (Figure <a href="#petr70154-supitem-0001" class="usa-link">S1B</a>, log rank <em>p</em> = 0.711) than those with non‐HLHS UVH. Similar stratification revealed no significant differences in post‐transplant survival (Figure <a href="#petr70154-supitem-0001" class="usa-link">S1C</a>, log rank <em>p</em> = 0.939 and Figure <a href="#petr70154-supitem-0001" class="usa-link">S1D</a>, log rank <em>p</em> = 0.812). Waiting list mortality and post‐transplant survival did not differ significantly depending on CM phenotype (Figure <a href="#petr70154-supitem-0001" class="usa-link">S1E</a>, log‐rank <em>p =</em> 0.472 and Figure <a href="#petr70154-supitem-0001" class="usa-link">S1F</a>, log rank <em>p</em> = 0.843).</p></section><section id="petr70154-sec-0020"><h4 class="pmc_sec_title">3.6.2. Short‐ and Long‐Term MCS in pHTx Recipients</h4>
<p>Transplantations from VAD and ECMO were more frequent in the contemporary era (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>). Pre‐pHTx VAD did not affect post‐transplant survival (Figure <a href="#petr70154-fig-0004" class="usa-link">4A</a>, log‐rank <em>p</em> = 0.733). Children with VAD after pHTx (Figure <a href="#petr70154-fig-0004" class="usa-link">4B</a>, log‐rank <em>p</em> &lt; 0.001) as well as pHTx from ECMO (Figure <a href="#petr70154-fig-0004" class="usa-link">4C</a>, log‐rank test <em>p</em> = 0.022) and ECMO after pHTx (Figure <a href="#petr70154-fig-0004" class="usa-link">4D</a>, log‐rank test <em>p</em> = 0.010) showed significantly worse survival.</p>
<figure class="fig xbox font-sm" id="petr70154-fig-0004"><h5 class="obj_head">FIGURE 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/8c4cbdcf4a9b/PETR-29-e70154-g005.jpg" loading="lazy" id="jats-graphic-9" height="910" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>MCS and PVRi as determinants of post‐transplant outcomes. Kaplan–Meier estimated post‐transplant survival for pHTx recipients with pre‐transplant (A) and post‐transplant (B) VAD, as well as pre‐transplant (C) and post‐transplant (D) ECMO. Data on pre‐ and post‐transplant VAD was available for 182 and 179 patients, respectively, and data on pre‐ and post‐transplant ECMO was available for 180 and 176 patients, respectively. PVRi at baseline (<em>n</em> = 99) and post‐AVT (<em>n</em> = 30) are shown in (E), and paired measurements (<em>n</em> = 29) displayed in (F). Paired measurements revealed that only two patients were transplanted with PVRi over 6, post‐AVT. Kaplan–Meier estimated post‐transplant survival for pHTx recipients with baseline PVRi &lt; 6 WU·m<sup>2</sup> or ≥ 6 WU·m<sup>2</sup> (G), according to data availability outlined above. Linear regression analysis for the correlation between baseline or post‐AVT PVRi and years of post‐transplant survival (H). AVT, acute vasoreactivity test; ECMO, extra‐corporeal mechanical oxygenation; PVRi, pulmonary vascular resistance index; VAD, ventricular assist device; WU·m<sup>2</sup>, Woods units.</p></figcaption></figure></section><section id="petr70154-sec-0021"><h4 class="pmc_sec_title">3.6.3. Pulmonary Hypertension With Elevated Pre‐Transplant PVRi
</h4>
<p>In 99 pHTx recipients with available baseline pre‐transplant PVRi data, median PVRi was 3.3 indexed Woods Units (WU·m<sup>2</sup>) (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>, Figure <a href="#petr70154-fig-0004" class="usa-link">4E</a>). Post‐AVT PVRi measurements were available in 30 patients with a median of 3.4 WU·m<sup>2</sup> (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>, Figure <a href="#petr70154-fig-0004" class="usa-link">4E</a>). Paired pre‐ and post‐AVT measurements were available in 29 patients, revealing post‐AVT PVRi &lt; 6 WU·m<sup>2</sup> in all but two patients (Figure <a href="#petr70154-fig-0004" class="usa-link">4F</a>). When stratifying post‐transplant survival by baseline PVRi &lt; 6 WU·m<sup>2</sup> or ≥ 6 WU·m<sup>2</sup> there was no statistically significant difference in survival (Figure <a href="#petr70154-fig-0004" class="usa-link">4G</a>, log‐rank test <em>p</em> = 0.107). There was no significant correlation between pre‐transplant PVRi at baseline (r<sup>2</sup> = 0.006, <em>p</em> = 0.419) or post‐AVT (<em>r</em>
<sup>2</sup> = 0.033, <em>p</em> = 0.334) and post‐pHTx survival time (Figure <a href="#petr70154-fig-0004" class="usa-link">4H</a>).</p></section><section id="petr70154-sec-0022"><h4 class="pmc_sec_title">3.6.4. 
ABO‐Incompatible pHTx and Transplantation Against Positive Crossmatch</h4>
<p>The percentage of major ABOi increased over time, from 2.9% in ERA I to 13.3% of all pHTx in ERA II (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>, <em>p</em> = 0.060). Twelve of the 17 ABOi recipients (70.6%) were younger than 24 months of age at the time of transplant, with the oldest recipient being 5 years and 2 months at ABOi transplant. Survival after pHTx with major ABOi was not significantly worse when compared to ABO‐compatible (ABOc) transplantation (Figure <a href="#petr70154-fig-0005" class="usa-link">5A</a>, log rank <em>p</em> = 0.049). Five patients (2.9%) underwent transplantation against a positive crossmatch, deemed positive either on CDC following treatment with DTT or on flow cytometry crossmatch test, all in ERA II (Table <a href="#petr70154-tbl-0002" class="usa-link">2</a>, <em>p</em> = 0.089).</p>
<figure class="fig xbox font-sm" id="petr70154-fig-0005"><h5 class="obj_head">FIGURE 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/2e52b531f2cd/PETR-29-e70154-g004.jpg" loading="lazy" id="jats-graphic-11" height="750" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>ABO‐incompatible transplant, immunological risk status and DSA. Kaplan–Meier estimated post‐transplant survival for pHTx recipients undergoing major ABOi transplantation or ABOc/minor ABOi transplantation, 1989–2023 (A). Data on blood group compatibility was lacking for two patients, why <em>n</em> = 183 in A. Kaplan–Meier estimated post‐transplant survival for pHTx recipients by immunological risk status, 2009–2023 (B). Frequencies of the different types of DSA (C) and whether they were preformed or discovered de novo (D) are shown. ABOc, ABO‐compatible transplantation; ABOi, ABO‐incompatible transplantation; DSA, donor‐specific antibodies.</p></figcaption></figure></section><section id="petr70154-sec-0023"><h4 class="pmc_sec_title">3.6.5. Immunological Risk and HLA‐DSA in Graft Recipients During the Contemporary Era, 2009–2023</h4>
<p>Immunology data at pHTx for recipients between 2009 and 2023, including selected baseline characteristics for recipients and donors, stratified by immunological risk, are shown in Table <a href="#petr70154-tbl-0004" class="usa-link">4</a>.</p>
<section class="tw xbox font-sm" id="petr70154-tbl-0004"><h5 class="obj_head">TABLE 4.</h5>
<div class="caption p"><p>Immunological risk, immunological data, and characteristics, 2009–2023.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Normal immunological risk (<em>n</em> = 62)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Elevated immunological risk<a href="#petr70154-note-0021" class="usa-link">
<sup>a</sup>
</a> (<em>n</em> = 42)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">High immunological risk<a href="#petr70154-note-0022" class="usa-link">
<sup>b</sup>
</a> (<em>n</em> = 9)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="5" valign="top" rowspan="1">Recipient</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age (years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.2 (IQR 2.6–14.4, range 25 days‐18.7 years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.5 (IQR 7.2–15.0, range 1.1–17.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.5 (IQR 9.4–14.9, range 4.2–16.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.291</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">&lt; 1 year</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (12.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.029</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gender (female)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (45.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19 (45.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (33.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.790</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">Diagnosis</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">CHD</td>
<td align="center" valign="top" rowspan="1" colspan="1">23 (37.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (28.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (55.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.282</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">CM</td>
<td align="center" valign="top" rowspan="1" colspan="1">39 (62.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (71.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (44.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Preoperative VAD</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 (32.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13 (31.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (44.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.731</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Preoperative ECMO</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (9.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (11.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.620</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">Donor</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.5 (IQR 4–25, range 0–59)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28 (IQR 11–47, range 0–53)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18 (IQR 13–22, range 5–58)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.007</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gender</td>
<td align="center" valign="top" rowspan="1" colspan="1">32 (52.5%), <em>n</em> = 61</td>
<td align="center" valign="top" rowspan="1" colspan="1">24 (57.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (55.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.894</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Wait list duration</td>
<td align="center" valign="top" rowspan="1" colspan="1">83 (23–178)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64.5 (9–187)</td>
<td align="center" valign="top" rowspan="1" colspan="1">72 (50–115)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.752</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Cold ischemic time</td>
<td align="center" valign="top" rowspan="1" colspan="1">198 + −69</td>
<td align="center" valign="top" rowspan="1" colspan="1">200 + −62</td>
<td align="center" valign="top" rowspan="1" colspan="1">205 + −56</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.906</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">ABOi</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (16.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (11.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.443</td>
</tr>
<tr><td align="left" colspan="5" valign="top" rowspan="1">Immunology</td></tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">vPRA</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">HLA‐ab with MFI &gt; 1000 (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="top" rowspan="1" colspan="1">28.4 (10.4–53.1), <em>n</em> = 38</td>
<td align="center" valign="top" rowspan="1" colspan="1">95.6 (70.3–98.5), <em>n</em> = 9</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">HLA‐ab with MFI &gt; 5000 (%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="top" rowspan="1" colspan="1">52.8 (28.4–70.2), <em>n</em> = 9</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">Cumulative MFI</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">HLA with MFI &gt; 1000</td>
<td align="center" valign="top" rowspan="1" colspan="1">N/A</td>
<td align="center" valign="top" rowspan="1" colspan="1">4600 (2100–7200)</td>
<td align="center" valign="top" rowspan="1" colspan="1">62 000 (17000–180 000), <em>n</em> = 8</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">HLA‐A, ‐B and ‐DR mismatches</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.631</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (1.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (7.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (11.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">11 (17.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (9.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (22.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (27.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (14.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (11.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (24.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (33.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (44.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">15 (24.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14 (33.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (11.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">HLA‐DQ mismatches</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 51</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 41</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<em>n</em> = 9</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">0</td>
<td align="center" valign="top" rowspan="1" colspan="1">7 (13.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (19.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0 (0.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.647</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (43.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16 (39.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5 (55.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">22 (43.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17 (41.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (44.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="5" valign="top" rowspan="1">Clinically significant DSA<a href="#petr70154-note-0023" class="usa-link">
<sup>c</sup>
</a>
</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">De novo and/or preformed</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (6.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 (28.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9 (100.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/petr70154-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="petr70154-note-0019"><p>
<em>Note:</em> Variables are described using frequencies and percentages for categorical variables and median with interquartile range for continuous variables. Continuous variables were compared by Kruskal‐Wallis test. Binary and categorical variables were compared by Pearson <em>χ</em>
<sup>2</sup> test.</p></div>
<div class="fn" id="petr70154-note-0020"><p>Abbreviations: ABOi, ABO‐incompatible; CHD, congenital heart disease; CM, cardiomyopathy; DSA, donor specific antibody; ECMO, extra‐corporeal membrane oxygenation; HLA, human leukocyte antigen; MFI, mean fluorescence intensity; PRA, panel reactive antibody; VAD, ventricular assist device.</p></div>
<div class="fn" id="petr70154-note-0021">
<sup>
<sup>a</sup>
</sup><p class="display-inline">If a patient displayed any HLA‐antibodies with an MFI &gt; 1000, they were considered immunized.</p>
</div>
<div class="fn" id="petr70154-note-0022">
<sup>
<sup>b</sup>
</sup><p class="display-inline">If a patient displayed any HLA‐antibodies with an MFI &gt; 5000, they were considered highly immunized.</p>
</div>
<div class="fn" id="petr70154-note-0023">
<sup>
<sup>c</sup>
</sup><p class="display-inline">For HLA‐A, HLA‐B, HLA‐DR and HLA‐DQ DSA, both <em>de novo</em> and preformed, antibodies were considered clinically significant if MFI &gt; 1000. For HLA‐Cw, HLA‐DP and HLA‐DR3/4/5, both <em>de novo</em> and preformed, antibodies were considered clinically significant if MFI &gt; 2000.</p>
</div>
</div></section><section id="petr70154-sec-0024"><h5 class="pmc_sec_title">3.6.5.1. Pre‐Transplant Immunological Risk and Degree of Matching</h5>
<p>In children with elevated immunological risk, the median vPRA value for preformed HLA with MFI &gt; 1000 was 28.4%. The median cumulative MFI was 4700 for these patients. In recipients with high immunological risk, the median vPRA for preformed HLA with MFI &gt; 1000 was 95.6%. The median cumulative MFI was 62 000 in this group (Table <a href="#petr70154-tbl-0004" class="usa-link">4</a>, both with <em>p</em> &lt; 0.001). To investigate the impact of singular strong HLA‐antibodies on recipient pre‐pHTx immunization status, an additional vPRA value was calculated in patients at high immunological risk that only included preformed HLA with MFI &gt; 5000. The median vPRA for these HLA was 52.8%, thus comprising &gt; 50% of the total vPRA for all significant HLA (Table <a href="#petr70154-tbl-0004" class="usa-link">4</a>). In children at elevated and/or high immunological risk, DSA were present or developed to a greater extent than in non‐immunized children (Table <a href="#petr70154-tbl-0004" class="usa-link">4</a>, <em>p</em> &lt; 0.001). Post‐transplant survival was not statistically different for recipients with high immunological risk (Figure <a href="#petr70154-fig-0005" class="usa-link">5B</a>, log rank <em>p</em> = 0.101).</p></section><section id="petr70154-sec-0025"><h5 class="pmc_sec_title">3.6.5.2. Clinically Significant DSA; HLA Specificity and Post‐Transplant Development</h5>
<p>Clinically significant DSAs, pre‐formed and <em>de novo</em>, in pHTx recipients from 2009 to 2023 are listed in Table <a href="#petr70154-supitem-0001" class="usa-link">S4</a>. DSAs were present, or developed, in 22.1% (<em>n</em> = 25) of all recipients during the contemporary era. The frequency of DSAs specific for different HLAs, pre‐formed and <em>de novo</em>, is presented in Figure <a href="#petr70154-fig-0005" class="usa-link">5C,D</a>. HLA‐DQ DSAs, constituting 45.9% of all clinically significant dnDSAs detected in recipients (Figure <a href="#petr70154-fig-0005" class="usa-link">5C</a>), were observed in 86.7% of all patients who developed dnDSAs. HLA‐DQ DSAs could be detected within the first month post‐pHTx (Table <a href="#petr70154-supitem-0001" class="usa-link">S4</a>). MFI values for HLA‐DQ DSAs were plotted over time for all individual patients with lab screen analyses at &gt; 4 separate time points (<em>n</em> = 8) and correlated with key clinical events and alterations in immunosuppression (Figure <a href="#petr70154-fig-0006" class="usa-link">6A–H</a>).</p>
<figure class="fig xbox font-sm" id="petr70154-fig-0006"><h6 class="obj_head">FIGURE 6.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af75/12358703/bb15aa2c164b/PETR-29-e70154-g007.jpg" loading="lazy" id="jats-graphic-13" height="1056" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/petr70154-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Management and monitoring of post‐transplant DQ‐type antibodies. MFI values of DQ‐type DSA were plotted over time, to visualize DSA development over time. Patient medical records were investigated to highlight what clinical measures were taken to combat and/or monitor a rise in MFI. A short description of the medical background is provided in the yellow box belonging to each graph. MFI &gt; 25 000 is generally not reported as the analysis is saturated around this value, although specified here to provide an accurate description of the investigated values. ACR, acute cellular rejection; ATG, anti‐thymocyte globulin; CHD, congenital heart disease; CM, cardiomyopathy; DSA, donor‐specific antibodies; ECMO, extra‐corporeal membrane oxygenation; HTAD, hereditary thoracic aorta disease; IVIG, intravenous immunoglobulin; MFI, mean fluorescence intensity; MMF, mycophenolate mofetil; pAMR, pathological grade of antibody‐mediated rejection; pHTx, pediatric heart transplantation.</p></figcaption></figure></section></section></section></section><section id="petr70154-sec-0026"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>The current study complements previous data reported by Gilljam et al., describing patient characteristics and survival until 2009 among the first 135 children listed for pHTx in Sweden [<a href="#petr70154-bib-0001" class="usa-link" aria-describedby="petr70154-bib-0001">1</a>]. Additionally, actual 1‐year and 10‐year survival of 93% and 72%, respectively, was reported for children from the Gothenburg cohort between 1990 and 2014 [<a href="#petr70154-bib-0022" class="usa-link" aria-describedby="petr70154-bib-0022">22</a>]. The present study investigates variables that have not been previously reported for the Swedish pHTx cohort, including data on MCS, elevated PVRi, ABO‐incompatible transplantation, immunological risk, and DSA‐status.</p>
<p>Since 2009, Sweden has experienced a significant decrease in waiting list mortality; although our data implicates that high infant waiting list mortality remains a challenge in Sweden, as it does globally [<a href="#petr70154-bib-0023" class="usa-link" aria-describedby="petr70154-bib-0023">23</a>]. Overall waiting list mortality 1989–2023 (18.9%) is comparable to the latest report from the UNOS database denoting a 16% waiting list mortality rate during the period 1999–2023 in the United States [<a href="#petr70154-bib-0024" class="usa-link" aria-describedby="petr70154-bib-0024">24</a>]. More importantly, waiting list mortality in Sweden had decreased to 8.8% between 2009 and 2023.</p>
<p>Increased waiting list duration was observed in ERA II, most likely due to improved waiting list survival. The increased utilization of durable long‐term MCS support, especially in small children and infants, may be an important contributor to both the increased waiting list duration and waiting list survival. Recently implemented Scandiatransplant waiting list regulations state that all hospital‐bound patients, with a body weight &lt; 25 kg and supported by long‐term VAD, are to be considered candidates for urgent call listing after 3 months [<a href="#petr70154-bib-0025" class="usa-link" aria-describedby="petr70154-bib-0025">25</a>]. The change in policy will hopefully, without altering the number of available organs, level out differences in offers between patients on VAD and patients on inotropes in the intensive care unit (currently considered urgent at waiting list entry). Collaborative efforts within Scandiatransplant aim to optimize organ allocation [<a href="#petr70154-bib-0002" class="usa-link" aria-describedby="petr70154-bib-0002">2</a>]. In recent years, Scandiatransplant has had a net export of organs in relation to other European organ allocation organizations [<a href="#petr70154-bib-0026" class="usa-link" aria-describedby="petr70154-bib-0026">26</a>], highlighting the efficient utility of available donors in the region. Utilization of DCD donors in carefully selected recipients within Scandiatransplant could contribute to a greater donor pool, although the true long‐term outcomes in pediatric recipients of DCD organs are yet unknown [<a href="#petr70154-bib-0027" class="usa-link" aria-describedby="petr70154-bib-0027">27</a>].</p>
<p>An increase in listing, but more prominently in pHTx, incidence was seen in ERA II. The combination of an increased listing incidence among children, a longer time on the waiting list, and lower waiting list mortality suggests that children listed during ERA II likely were in a better overall clinical condition at waiting list entry than patients in ERA I, and that those in more critical heart failure benefited from the increased availability of VAD and improved medical and surgical/interventional treatment during the contemporary era.</p>
<p>Transplantation during the contemporary era was not a significant determinant of post‐transplant outcome in our analysis, most likely attributable to the low early mortality observed in Swedish pHTx practice. Improvements in early mortality in transplant practice have been postulated to be greater over time than improvements in late mortality [<a href="#petr70154-bib-0028" class="usa-link" aria-describedby="petr70154-bib-0028">28</a>], which may explain why the improvement in survival during ERA II in Sweden did not reach significance. Short‐ and long‐term post‐transplant outcomes in the Swedish cohort are comparable to recent reports from corresponding nationwide cohorts, both regionally and internationally [<a href="#petr70154-bib-0029" class="usa-link" aria-describedby="petr70154-bib-0029">29</a>, <a href="#petr70154-bib-0030" class="usa-link" aria-describedby="petr70154-bib-0030">30</a>, <a href="#petr70154-bib-0031" class="usa-link" aria-describedby="petr70154-bib-0031">31</a>]. The contribution of free accessible health care, the availability of high‐quality national heart failure follow‐up programs, as well as a high public awareness of available treatments all likely contribute to the good outcomes presented here. We observed similar outcomes for children with CHD and with CMs post‐transplant, contrary to recently published ISHLT reports [<a href="#petr70154-bib-0032" class="usa-link" aria-describedby="petr70154-bib-0032">32</a>]. This finding is also in contrast with recently published data from Scandiatransplant [<a href="#petr70154-bib-0033" class="usa-link" aria-describedby="petr70154-bib-0033">33</a>] where CHD patients had worse survival after pediatric heart transplant compared to non‐CHD patients. The challenge of pHTx in CHD patients is mainly comprised of two issues: surgical challenges in the reoperation setting and significant immunization due to prior surgery, transfusion, and circulatory support. Small surgical teams that maintain adequate volume and training, as well as close‐knit collaboration with immunologists at both Swedish pHTx centers may provide explanations for these outcomes. However, when comparing the Swedish cohort with largely North American registries like the ISHLT, Pediatric Heart Transplantation Society (PHTS) [<a href="#petr70154-bib-0034" class="usa-link" aria-describedby="petr70154-bib-0034">34</a>] and UNOS [<a href="#petr70154-bib-0029" class="usa-link" aria-describedby="petr70154-bib-0029">29</a>], the proportion of CHD and infants is lower in our cohort. Therefore, our results on CHD transplant may also be due to differences between our cohort and those of the ISHLT and PHTS.</p>
<p>The most common causes of post‐transplant death; graft failure, cardiovascular events, and malignancy correspond to the most common causes of death in the ISHLT registry [<a href="#petr70154-bib-0035" class="usa-link" aria-describedby="petr70154-bib-0035">35</a>]; although we did not investigate changes over time in our cohort due to the low number of events.</p>
<p>Our data supports previous reports suggesting that post‐transplant survival is independent of the use of pre‐transplant VAD in children [<a href="#petr70154-bib-0006" class="usa-link" aria-describedby="petr70154-bib-0006">6</a>, <a href="#petr70154-bib-0011" class="usa-link" aria-describedby="petr70154-bib-0011">11</a>, <a href="#petr70154-bib-0036" class="usa-link" aria-describedby="petr70154-bib-0036">36</a>, <a href="#petr70154-bib-0037" class="usa-link" aria-describedby="petr70154-bib-0037">37</a>]. In Kaplan–Meier analysis, impeded survival was observed in children with post‐transplant VAD as well as pre‐ and post‐transplant ECMO in the Swedish cohort, like previously published data from the PHTS [<a href="#petr70154-bib-0038" class="usa-link" aria-describedby="petr70154-bib-0038">38</a>]. Pre‐transplant ECMO was, however, not deemed a risk factor for worse post‐transplant survival in our stepwise Cox proportional hazard regression analysis; although we acknowledge that this is most likely a type II statistical error. Post‐transplant ECMO and VAD could be surrogate markers for poor recipient status, donor and/or graft status; however, even in patients on post‐transplant MCS with good prognosis, associated events such as pump thrombosis, stroke, and infection could cause clinical deterioration [<a href="#petr70154-bib-0009" class="usa-link" aria-describedby="petr70154-bib-0009">9</a>, <a href="#petr70154-bib-0039" class="usa-link" aria-describedby="petr70154-bib-0039">39</a>].</p>
<p>Pre‐ and post‐transplant kidney function has a significant impact on pHTx outcomes [<a href="#petr70154-bib-0040" class="usa-link" aria-describedby="petr70154-bib-0040">40</a>], but our analysis could not highlight elevated pretransplant GFR as a determinant of post‐pHTx outcome. A decrease in kidney function post‐transplant can be the result of chronic exposure to calcineurin inhibitors (tacrolimus). In recent years, the addition of Everolimus in a CNI‐sparing effort has been associated with improved kidney function in pediatric patients [<a href="#petr70154-bib-0041" class="usa-link" aria-describedby="petr70154-bib-0041">41</a>, <a href="#petr70154-bib-0042" class="usa-link" aria-describedby="petr70154-bib-0042">42</a>]. We observed a trend of increased Everolimus use over time; however, we had no follow‐up data to investigate its possible impact on kidney function.</p>
<p>The dogma of elevated PVRi &gt; 6 WU·m<sup>2</sup> as an absolute contraindication for pHTx has been challenged in recent years [<a href="#petr70154-bib-0043" class="usa-link" aria-describedby="petr70154-bib-0043">43</a>], and there is a lack of international consensus regarding important management aspects in patients with elevated PVRi [<a href="#petr70154-bib-0012" class="usa-link" aria-describedby="petr70154-bib-0012">12</a>, <a href="#petr70154-bib-0015" class="usa-link" aria-describedby="petr70154-bib-0015">15</a>]. Long‐term outcomes were somewhat impeded for patients with PVRi ≥ 6, although not statistically significant, as compared to those with PVRi &lt; 6. Hemodynamics following AVT was available for 30 patients, with 29 having paired measurements pre‐ and post‐AVT. Only two patients were transplanted with a post‐AVT PVRi of &gt; 6, indicating that PVRi &gt; 6 was reversible with pulmonary vasodilators upon AVT in most children. Post‐AVT PVRi &gt; 6 seems to have been a, possibly unspoken, cut‐off for pHTx eligibility in Sweden. As recently highlighted in a Scientific Statement from the American Heart Association [<a href="#petr70154-bib-0012" class="usa-link" aria-describedby="petr70154-bib-0012">12</a>], PVRi should be interpreted with caution, as many factors (sedation, shunts, and poor cardiac output) can influence the calculation of PVRi in children. Nonetheless, this data supports that children with baseline PVRi of &gt; 6 should undergo AVT and not be automatically precluded from pHTx, and that most children can reach below this cut‐off with adequate treatment. The possibility of implantable hemodynamic monitors in children may increase the accuracy of pulmonary hypertension monitoring in the setting of heart failure and thus optimize pre‐pHTx management and timing of pHTx [<a href="#petr70154-bib-0044" class="usa-link" aria-describedby="petr70154-bib-0044">44</a>, <a href="#petr70154-bib-0045" class="usa-link" aria-describedby="petr70154-bib-0045">45</a>]. One limitation of our study was the lack of baseline hemodynamic data for all listed patients, why our analysis could have been subject to selection bias.</p>
<p>ABOi transplantation and transplant against positive crossmatch was performed to a greater extent during ERA II, as new methods became available during this era. Our data support that ABOi recipients do not have worse short‐ and medium‐term outcomes after pHTx, in line with recent reports from the United States [<a href="#petr70154-bib-0046" class="usa-link" aria-describedby="petr70154-bib-0046">46</a>]. Implementation of perioperative immunoadsorption column protocols in Sweden and globally [<a href="#petr70154-bib-0047" class="usa-link" aria-describedby="petr70154-bib-0047">47</a>] has allowed for efficient management of anti‐A and anti‐B antibody titers in recipients.</p>
<p>The clinical utility of repeated post‐transplant measurements of anti‐HLA DSA in solid organ transplant recipients was highlighted as an area of interest for future study by the Sensitization in transplantation: assessment of risk (STAR) working group [<a href="#petr70154-bib-0048" class="usa-link" aria-describedby="petr70154-bib-0048">48</a>] and has been suggested to be an important tool for risk stratification of heart transplant recipients as well as a prognostic factor predicting CAV [<a href="#petr70154-bib-0049" class="usa-link" aria-describedby="petr70154-bib-0049">49</a>]. Descriptions of pediatric cohorts are sparse [<a href="#petr70154-bib-0048" class="usa-link" aria-describedby="petr70154-bib-0048">48</a>]. We provide a detailed description of immunological data in contemporary pHTx recipients, 2009–2023, and opted to define immunological risk status based on the presence of prominent anti‐HLA antibodies (MFI), rather than the width of the sensitization (vPRA). Additionally, we calculated two separate vPRA values to distinguish the contribution of strong individual anti‐HLA to the vPRA value. Children at high immunological risk, with any anti‐HLA antibody with MFI &gt; 5000, displayed a high vPRA (median 96.3%) for all HLA‐antibodies with MFI &gt; 1000. In the same patients, vPRA for anti‐HLA with MFI &gt; 5000 was a median 50.1%, suggesting that a large part of the vPRA might be attributable to a limited number of strong anti‐HLA. Only a small subset of patients proved at high immunological risk in our cohort but demonstrated a trend towards worse survival in Kaplan–Meier analysis.</p></section><section id="petr70154-sec-0027"><h2 class="pmc_sec_title">5. Conclusions</h2>
<p>Early and long‐term outcomes of heart listing and pHTx in Sweden have improved continuously over the last 35 years. Data presented here support the notion that elevated pre‐transplant baseline PVRi &gt; 6 WU·m<sup>2</sup> is not an absolute contraindication to pHTx, and that AVT is an important tool for additional evaluation of PVRi. Reported outcomes in the Swedish cohort are comparable with outcomes reported by larger databases worldwide.</p></section><section id="petr70154-sec-0028"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data. O.v.d.H., K.T.‐L., and M.O. drafted the manuscript. All authors edited, revised, and approved the final version of the manuscript.</p></section><section id="petr70154-sec-0030"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="sec30"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="petr70154-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358703/bin/PETR-29-e70154-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">PETR-29-e70154-s001.docx</a><sup> (293.7KB, docx) </sup>
</div></div></section></section><section id="petr70154-sec-0029" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We acknowledge Scandiatransplant for provision of its registry data. We are grateful towards Dr. Joanna‐Maria Papageorgiou for the contribution of patient data. Flow charts were created with <a href="http://lucid.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">lucid.com</a>.</p></section><section id="notes1"><p>

van der Have O., Wåhlander H., Hofbard T., et al., “Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden,” Pediatric Transplantation
29, no. 6 (2025): e70154, 10.1111/petr.70154.
</p>
<section id="petr70154-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="petr70154-note-0001"><p>
<strong>Funding:</strong> This work was supported by the Swedish Heart‐Lung Foundation (20230545 [K.T.‐L.] and 20220591 [K.T.‐L.]), Skane County Council (2022‐Projekt0168 [K.T.‐L.]), Knut and Alice Wallenberg Foundation [K.T.‐L.], the Swedish Research Council (2022‐00683 [K.T.‐L] and 2023‐03184 [J.N.]), by grants ALFGBG‐1006863 from the Swedish state under the agreement between the Swedish government and the county councils (J.H.) and the Fund for Transplant Research at the Centre for Transplantation, Skane University Hospital in Lund, Sweden (O.v.d.H.).</p></div></div></section></section><section id="petr70154-sec-0032"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="petr70154-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="petr70154-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="petr70154-bib-0001">
<span class="label">1.</span><cite>
Gilljam T., Higgins T., Bennhagen R., and Wahlander H., “First Two Decades of Paediatric Heart Transplantation in Sweden—Outcome of Listing and Post‐Transplant Results,” Acta Paediatrica
100, no. 11 (2011): 1442–1447.
</cite> [<a href="https://doi.org/10.1111/j.1651-2227.2011.02377.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21645110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Paediatrica&amp;title=First%20Two%20Decades%20of%20Paediatric%20Heart%20Transplantation%20in%20Sweden%E2%80%94Outcome%20of%20Listing%20and%20Post%E2%80%90Transplant%20Results&amp;author=T.%20Gilljam&amp;author=T.%20Higgins&amp;author=R.%20Bennhagen&amp;author=H.%20Wahlander&amp;volume=100&amp;issue=11&amp;publication_year=2011&amp;pages=1442-1447&amp;pmid=21645110&amp;doi=10.1111/j.1651-2227.2011.02377.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0002">
<span class="label">2.</span><cite>
Madsen M., Asmundsson P., Brekke I. B., et al., “Scandiatransplant: Thirty Years of Cooperation in Organ Transplantation in the Nordic Countries,” Clinical Transplants
121 (1998): 31.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10503091/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Transplants&amp;title=Scandiatransplant:%20Thirty%20Years%20of%20Cooperation%20in%20Organ%20Transplantation%20in%20the%20Nordic%20Countries&amp;author=M.%20Madsen&amp;author=P.%20Asmundsson&amp;author=I.%20B.%20Brekke&amp;volume=121&amp;publication_year=1998&amp;pages=31&amp;pmid=10503091&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0003">
<span class="label">3.</span><cite>
Sutcliffe D. L., Pruitt E., Cantor R. S., et al., “Post‐Transplant Outcomes in Pediatric Ventricular Assist Device Patients: A PediMACS‐Pediatric Heart Transplant Study Linkage Analysis,” Journal of Heart and Lung Transplantation
37, no. 6 (2018): 715–722.</cite> [<a href="https://doi.org/10.1016/j.healun.2017.12.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29373179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Post%E2%80%90Transplant%20Outcomes%20in%20Pediatric%20Ventricular%20Assist%20Device%20Patients:%20A%20PediMACS%E2%80%90Pediatric%20Heart%20Transplant%20Study%20Linkage%20Analysis&amp;author=D.%20L.%20Sutcliffe&amp;author=E.%20Pruitt&amp;author=R.%20S.%20Cantor&amp;volume=37&amp;issue=6&amp;publication_year=2018&amp;pages=715-722&amp;pmid=29373179&amp;doi=10.1016/j.healun.2017.12.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0004">
<span class="label">4.</span><cite>
Dipchand A. I. and Webber S. A., “Pediatric Heart Transplantation: Looking Forward After Five Decades of Learning,” Pediatric Transplantation
28, no. 1 (2024): e14675.
</cite> [<a href="https://doi.org/10.1111/petr.14675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38062996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Pediatric%20Heart%20Transplantation:%20Looking%20Forward%20After%20Five%20Decades%20of%20Learning&amp;author=A.%20I.%20Dipchand&amp;author=S.%20A.%20Webber&amp;volume=28&amp;issue=1&amp;publication_year=2024&amp;pages=e14675&amp;pmid=38062996&amp;doi=10.1111/petr.14675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0005">
<span class="label">5.</span><cite>
Rohde S., van Puyvelde J., Veen K. M., et al., “The European Registry for Patients With Mechanical Circulatory Support (EUROMACS): Fourth Paediatric EUROMACS (Paedi‐EUROMACS) Report,” European Journal of Cardio‐Thoracic Surgery
66 (2024): ezae276.
</cite> [<a href="https://doi.org/10.1093/ejcts/ezae276" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39029919/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Cardio%E2%80%90Thoracic%20Surgery&amp;title=The%20European%20Registry%20for%20Patients%20With%20Mechanical%20Circulatory%20Support%20(EUROMACS):%20Fourth%20Paediatric%20EUROMACS%20(Paedi%E2%80%90EUROMACS)%20Report&amp;author=S.%20Rohde&amp;author=J.%20van%20Puyvelde&amp;author=K.%20M.%20Veen&amp;volume=66&amp;publication_year=2024&amp;pages=ezae276&amp;pmid=39029919&amp;doi=10.1093/ejcts/ezae276&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0006">
<span class="label">6.</span><cite>
Kindel S. J. and Everitt M. D., “A Contemporary Review of Paediatric Heart Transplantation and Mechanical Circulatory Support,” Cardiology in the Young
26, no. 5 (2016): 851–859.
</cite> [<a href="https://doi.org/10.1017/S1047951116000184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26979140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiology%20in%20the%20Young&amp;title=A%20Contemporary%20Review%20of%20Paediatric%20Heart%20Transplantation%20and%20Mechanical%20Circulatory%20Support&amp;author=S.%20J.%20Kindel&amp;author=M.%20D.%20Everitt&amp;volume=26&amp;issue=5&amp;publication_year=2016&amp;pages=851-859&amp;pmid=26979140&amp;doi=10.1017/S1047951116000184&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0007">
<span class="label">7.</span><cite>
Morgan C. T., Manlhiot C., McCrindle B. W., and Dipchand A. I., “Outcome, Incidence and Risk Factors for Stroke After Pediatric Heart Transplantation: An Analysis of the International Society for Heart and Lung Transplantation Registry,” Journal of Heart and Lung Transplantation
35, no. 5 (2016): 597–602.</cite> [<a href="https://doi.org/10.1016/j.healun.2016.01.1226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26996929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Outcome,%20Incidence%20and%20Risk%20Factors%20for%20Stroke%20After%20Pediatric%20Heart%20Transplantation:%20An%20Analysis%20of%20the%20International%20Society%20for%20Heart%20and%20Lung%20Transplantation%20Registry&amp;author=C.%20T.%20Morgan&amp;author=C.%20Manlhiot&amp;author=B.%20W.%20McCrindle&amp;author=A.%20I.%20Dipchand&amp;volume=35&amp;issue=5&amp;publication_year=2016&amp;pages=597-602&amp;pmid=26996929&amp;doi=10.1016/j.healun.2016.01.1226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0008">
<span class="label">8.</span><cite>
Power A., Navaratnam M., Murray J. M., et al., “Adverse Events Associated With Cardiac Catheterization in Children Supported With Ventricular Assist Devices,” ASAIO Journal
68, no. 9 (2022): 1174–1181.
</cite> [<a href="https://doi.org/10.1097/MAT.0000000000001627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34967779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ASAIO%20Journal&amp;title=Adverse%20Events%20Associated%20With%20Cardiac%20Catheterization%20in%20Children%20Supported%20With%20Ventricular%20Assist%20Devices&amp;author=A.%20Power&amp;author=M.%20Navaratnam&amp;author=J.%20M.%20Murray&amp;volume=68&amp;issue=9&amp;publication_year=2022&amp;pages=1174-1181&amp;pmid=34967779&amp;doi=10.1097/MAT.0000000000001627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0009">
<span class="label">9.</span><cite>
George A. N., Hsia T. Y., Schievano S., and Bozkurt S., “Complications in Children With Ventricular Assist Devices: Systematic Review and Meta‐Analyses,” Heart Failure Reviews
27, no. 3 (2022): 903–913.
</cite> [<a href="https://doi.org/10.1007/s10741-021-10093-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33661404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Failure%20Reviews&amp;title=Complications%20in%20Children%20With%20Ventricular%20Assist%20Devices:%20Systematic%20Review%20and%20Meta%E2%80%90Analyses&amp;author=A.%20N.%20George&amp;author=T.%20Y.%20Hsia&amp;author=S.%20Schievano&amp;author=S.%20Bozkurt&amp;volume=27&amp;issue=3&amp;publication_year=2022&amp;pages=903-913&amp;pmid=33661404&amp;doi=10.1007/s10741-021-10093-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0010">
<span class="label">10.</span><cite>
Niebler R. A., Amdani S., Blume B., et al., “Stroke in Pediatric Ventricular Assist Device Patients—A Pedimacs Registry Analysis,” Journal of Heart and Lung Transplantation
40, no. 7 (2021): 662–670.</cite> [<a href="https://doi.org/10.1016/j.healun.2021.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33824064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Stroke%20in%20Pediatric%20Ventricular%20Assist%20Device%20Patients%E2%80%94A%20Pedimacs%20Registry%20Analysis&amp;author=R.%20A.%20Niebler&amp;author=S.%20Amdani&amp;author=B.%20Blume&amp;volume=40&amp;issue=7&amp;publication_year=2021&amp;pages=662-670&amp;pmid=33824064&amp;doi=10.1016/j.healun.2021.03.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0011">
<span class="label">11.</span><cite>
Marcos‐Alonso S., Gil N., García‐Guereta L., et al., “Impact of Mechanical Circulatory Support on Survival in Pediatric Heart Transplantation,” Pediatric Transplantation
24, no. 4 (2020): e13707.
</cite> [<a href="https://doi.org/10.1111/petr.13707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32212306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Impact%20of%20Mechanical%20Circulatory%20Support%20on%20Survival%20in%20Pediatric%20Heart%20Transplantation&amp;author=S.%20Marcos%E2%80%90Alonso&amp;author=N.%20Gil&amp;author=L.%20Garc%C3%ADa%E2%80%90Guereta&amp;volume=24&amp;issue=4&amp;publication_year=2020&amp;pages=e13707&amp;pmid=32212306&amp;doi=10.1111/petr.13707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0012">
<span class="label">12.</span><cite>
Hopper R. K., Hansmann G., Hollander S. A., et al., “Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension due to Left Heart Disease: A Scientific Statement From the American Heart Association,” Circulation. Heart Failure
29 (2024): e000086.</cite> [<a href="https://doi.org/10.1161/HHF.0000000000000086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39648916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation.%20Heart%20Failure&amp;title=Clinical%20Management%20and%20Transplant%20Considerations%20in%20Pediatric%20Pulmonary%20Hypertension%20due%20to%20Left%20Heart%20Disease:%20A%20Scientific%20Statement%20From%20the%20American%20Heart%20Association&amp;author=R.%20K.%20Hopper&amp;author=G.%20Hansmann&amp;author=S.%20A.%20Hollander&amp;volume=29&amp;publication_year=2024&amp;pages=e000086&amp;pmid=39648916&amp;doi=10.1161/HHF.0000000000000086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0013">
<span class="label">13.</span><cite>
Brittain E. L., Thenappan T., Huston J. H., et al., “Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association,” Circulation
146, no. 7 (2022): e73–e88.
</cite> [<a href="https://doi.org/10.1161/CIR.0000000000001079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9901193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35862198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Elucidating%20the%20Clinical%20Implications%20and%20Pathophysiology%20of%20Pulmonary%20Hypertension%20in%20Heart%20Failure%20With%20Preserved%20Ejection%20Fraction:%20A%20Call%20to%20Action:%20A%20Science%20Advisory%20From%20the%20American%20Heart%20Association&amp;author=E.%20L.%20Brittain&amp;author=T.%20Thenappan&amp;author=J.%20H.%20Huston&amp;volume=146&amp;issue=7&amp;publication_year=2022&amp;pages=e73-e88&amp;pmid=35862198&amp;doi=10.1161/CIR.0000000000001079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0014">
<span class="label">14.</span><cite>
Kulik T. J., “Pulmonary Hypertension Caused by Pulmonary Venous Hypertension,” Pulmonary Circulation
4, no. 4 (2014): 581–595.
</cite> [<a href="https://doi.org/10.1086/678471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4278619/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25610595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pulmonary%20Circulation&amp;title=Pulmonary%20Hypertension%20Caused%20by%20Pulmonary%20Venous%20Hypertension&amp;author=T.%20J.%20Kulik&amp;volume=4&amp;issue=4&amp;publication_year=2014&amp;pages=581-595&amp;pmid=25610595&amp;doi=10.1086/678471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0015">
<span class="label">15.</span><cite>
Hopper R. K., van der Have O., Hollander S. A., et al., “International Practice Heterogeneity in Pre‐Transplant Management of Pulmonary Hypertension Related to Pediatric Left Heart Disease,” Pediatric Transplantation
27, no. 2 (2023): e14461.
</cite> [<a href="https://doi.org/10.1111/petr.14461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36593638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=International%20Practice%20Heterogeneity%20in%20Pre%E2%80%90Transplant%20Management%20of%20Pulmonary%20Hypertension%20Related%20to%20Pediatric%20Left%20Heart%20Disease&amp;author=R.%20K.%20Hopper&amp;author=O.%20van%20der%20Have&amp;author=S.%20A.%20Hollander&amp;volume=27&amp;issue=2&amp;publication_year=2023&amp;pages=e14461&amp;pmid=36593638&amp;doi=10.1111/petr.14461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0016">
<span class="label">16.</span><cite>
Barten M. J., Schulz U., Beiras‐Fernandez A., et al., “The Clinical Impact of Donor‐Specific Antibodies in Heart Transplantation,” Transplantation Reviews (Orlando, Fla.)
32, no. 4 (2018): 207–217.
</cite> [<a href="https://doi.org/10.1016/j.trre.2018.05.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29804793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation%20Reviews%20(Orlando,%20Fla.)&amp;title=The%20Clinical%20Impact%20of%20Donor%E2%80%90Specific%20Antibodies%20in%20Heart%20Transplantation&amp;author=M.%20J.%20Barten&amp;author=U.%20Schulz&amp;author=A.%20Beiras%E2%80%90Fernandez&amp;volume=32&amp;issue=4&amp;publication_year=2018&amp;pages=207-217&amp;pmid=29804793&amp;doi=10.1016/j.trre.2018.05.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0017">
<span class="label">17.</span><cite>
Dipchand A. I., Webber S., Mason K., et al., “Incidence, Characterization, and Impact of Newly Detected Donor‐Specific Anti‐HLA Antibody in the First Year After Pediatric Heart Transplantation: A Report From the CTOTC‐04 Study,” American Journal of Transplantation
18, no. 9 (2018): 2163–2174.
</cite> [<a href="https://doi.org/10.1111/ajt.14691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6092243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29442424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Transplantation&amp;title=Incidence,%20Characterization,%20and%20Impact%20of%20Newly%20Detected%20Donor%E2%80%90Specific%20Anti%E2%80%90HLA%20Antibody%20in%20the%20First%20Year%20After%20Pediatric%20Heart%20Transplantation:%20A%20Report%20From%20the%20CTOTC%E2%80%9004%20Study&amp;author=A.%20I.%20Dipchand&amp;author=S.%20Webber&amp;author=K.%20Mason&amp;volume=18&amp;issue=9&amp;publication_year=2018&amp;pages=2163-2174&amp;pmid=29442424&amp;doi=10.1111/ajt.14691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0018">
<span class="label">18.</span><cite>
von Elm E., Altman D. G., Egger M., et al., “The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies,” Annals of Internal Medicine
147, no. 8 (2007): 573–577.
</cite> [<a href="https://doi.org/10.7326/0003-4819-147-8-200710160-00010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17938396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Internal%20Medicine&amp;title=The%20Strengthening%20the%20Reporting%20of%20Observational%20Studies%20in%20Epidemiology%20(STROBE)%20Statement:%20Guidelines%20for%20Reporting%20Observational%20Studies&amp;author=E.%20von%20Elm&amp;author=D.%20G.%20Altman&amp;author=M.%20Egger&amp;volume=147&amp;issue=8&amp;publication_year=2007&amp;pages=573-577&amp;pmid=17938396&amp;doi=10.7326/0003-4819-147-8-200710160-00010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0019">
<span class="label">19.</span><cite>
Benchimol E. I., Smeeth L., Guttmann A., et al., “The REporting of Studies Conducted Using Observational Routinely‐Collected Health Data (RECORD) Statement,” PLoS Medicine
12, no. 10 (2015): e1001885.
</cite> [<a href="https://doi.org/10.1371/journal.pmed.1001885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4595218/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26440803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Medicine&amp;title=The%20REporting%20of%20Studies%20Conducted%20Using%20Observational%20Routinely%E2%80%90Collected%20Health%20Data%20(RECORD)%20Statement&amp;author=E.%20I.%20Benchimol&amp;author=L.%20Smeeth&amp;author=A.%20Guttmann&amp;volume=12&amp;issue=10&amp;publication_year=2015&amp;pages=e1001885&amp;pmid=26440803&amp;doi=10.1371/journal.pmed.1001885&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0020">
<span class="label">20.</span><cite>
Tambur A. R., Campbell P., Claas F. H., et al., “Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report,” American Journal of Transplantation
18, no. 7 (2018): 1604–1614.
</cite> [<a href="https://doi.org/10.1111/ajt.14752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29603613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Transplantation&amp;title=Sensitization%20in%20Transplantation:%20Assessment%20of%20Risk%20(STAR)%202017%20Working%20Group%20Meeting%20Report&amp;author=A.%20R.%20Tambur&amp;author=P.%20Campbell&amp;author=F.%20H.%20Claas&amp;volume=18&amp;issue=7&amp;publication_year=2018&amp;pages=1604-1614&amp;pmid=29603613&amp;doi=10.1111/ajt.14752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0021">
<span class="label">21.</span><cite>
Peacock S., Briggs D., Barnardo M., et al., “BSHI/BTS Guidance on Crossmatching Before Deceased Donor Kidney Transplantation,” International Journal of Immunogenetics
49, no. 1 (2022): 22–29.
</cite> [<a href="https://doi.org/10.1111/iji.12558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9292213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34555264/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Immunogenetics&amp;title=BSHI/BTS%20Guidance%20on%20Crossmatching%20Before%20Deceased%20Donor%20Kidney%20Transplantation&amp;author=S.%20Peacock&amp;author=D.%20Briggs&amp;author=M.%20Barnardo&amp;volume=49&amp;issue=1&amp;publication_year=2022&amp;pages=22-29&amp;pmid=34555264&amp;doi=10.1111/iji.12558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0022">
<span class="label">22.</span><cite>
Dellgren G., Westerlind A., Liden H., et al., “Continuous Improvement in Outcome After Heart Transplantation ‐ Long‐Term Follow‐Up After Three Decades of Experience,” International Journal of Cardiology
231 (2017): 188–194.
</cite> [<a href="https://doi.org/10.1016/j.ijcard.2016.12.186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28087175/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cardiology&amp;title=Continuous%20Improvement%20in%20Outcome%20After%20Heart%20Transplantation%20%E2%80%90%20Long%E2%80%90Term%20Follow%E2%80%90Up%20After%20Three%20Decades%20of%20Experience&amp;author=G.%20Dellgren&amp;author=A.%20Westerlind&amp;author=H.%20Liden&amp;volume=231&amp;publication_year=2017&amp;pages=188-194&amp;pmid=28087175&amp;doi=10.1016/j.ijcard.2016.12.186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0023">
<span class="label">23.</span><cite>
Denfield S. W., Azeka E., Das B., et al., “Pediatric Cardiac Waitlist Mortality‐Still Too High,” Pediatric Transplantation
24, no. 3 (2020): e13671.
</cite> [<a href="https://doi.org/10.1111/petr.13671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32198830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Pediatric%20Cardiac%20Waitlist%20Mortality%E2%80%90Still%20Too%20High&amp;author=S.%20W.%20Denfield&amp;author=E.%20Azeka&amp;author=B.%20Das&amp;volume=24&amp;issue=3&amp;publication_year=2020&amp;pages=e13671&amp;pmid=32198830&amp;doi=10.1111/petr.13671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0024">
<span class="label">24.</span><cite>
Power A., Sweat K. R., Roth A., et al., “Contemporary Pediatric Heart Transplant Waitlist Mortality,” Journal of the American College of Cardiology
84, no. 7 (2024): 620–632.
</cite> [<a href="https://doi.org/10.1016/j.jacc.2024.05.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39111968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20College%20of%20Cardiology&amp;title=Contemporary%20Pediatric%20Heart%20Transplant%20Waitlist%20Mortality&amp;author=A.%20Power&amp;author=K.%20R.%20Sweat&amp;author=A.%20Roth&amp;volume=84&amp;issue=7&amp;publication_year=2024&amp;pages=620-632&amp;pmid=39111968&amp;doi=10.1016/j.jacc.2024.05.049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0025">
<span class="label">25.</span><cite>
Guidelines for Thoracic Organ Exchange in the Scandiatransplant Area (April 2023)
, “Guidelines for Organ Exchange in the Scandiatransplant Area,” (2023).</cite>
</li>
<li id="petr70154-bib-0026">
<span class="label">26.</span><cite>
Scandiatransplant
, “Scandiatransplant Annual Data Report 2024,” (2024), <a href="https://www.scandiatransplant.org/resources/annual-report" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.scandiatransplant.org/resources/annual‐report</a>.</cite>
</li>
<li id="petr70154-bib-0027">
<span class="label">27.</span><cite>
Kleinmahon J. A., Patel S. S., Auerbach S. R., Rossano J., and Everitt M. D., “Hearts Transplanted After Circulatory Death in Children: Analysis of the International Society for Heart and Lung Transplantation Registry,” Pediatric Transplantation
21, no. 8 (2017): 13064.</cite> [<a href="https://doi.org/10.1111/petr.13064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28940999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Hearts%20Transplanted%20After%20Circulatory%20Death%20in%20Children:%20Analysis%20of%20the%20International%20Society%20for%20Heart%20and%20Lung%20Transplantation%20Registry&amp;author=J.%20A.%20Kleinmahon&amp;author=S.%20S.%20Patel&amp;author=S.%20R.%20Auerbach&amp;author=J.%20Rossano&amp;author=M.%20D.%20Everitt&amp;volume=21&amp;issue=8&amp;publication_year=2017&amp;pages=13064&amp;pmid=28940999&amp;doi=10.1111/petr.13064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0028">
<span class="label">28.</span><cite>
Dharnidharka V. R., Lamb K. E., Zheng J., Schechtman K. B., and Meier‐Kriesche H. U., “Lack of Significant Improvements in Long‐Term Allograft Survival in Pediatric Solid Organ Transplantation: A US National Registry Analysis,” Pediatric Transplantation
19, no. 5 (2015): 477–483.
</cite> [<a href="https://doi.org/10.1111/petr.12465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25832769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Lack%20of%20Significant%20Improvements%20in%20Long%E2%80%90Term%20Allograft%20Survival%20in%20Pediatric%20Solid%20Organ%20Transplantation:%20A%20US%20National%20Registry%20Analysis&amp;author=V.%20R.%20Dharnidharka&amp;author=K.%20E.%20Lamb&amp;author=J.%20Zheng&amp;author=K.%20B.%20Schechtman&amp;author=H.%20U.%20Meier%E2%80%90Kriesche&amp;volume=19&amp;issue=5&amp;publication_year=2015&amp;pages=477-483&amp;pmid=25832769&amp;doi=10.1111/petr.12465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0029">
<span class="label">29.</span><cite>
Sharaf O. M., Bilgili A., Brennan Z., et al., “Pediatric Heart Transplantation Over 36 Years and Contemporary Volume‐Outcome Analysis of UNOS,” Annals of Thoracic Surgery
118, no. 6 (2024): 1288–1298.
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2024.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38777247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Thoracic%20Surgery&amp;title=Pediatric%20Heart%20Transplantation%20Over%2036%E2%80%89Years%20and%20Contemporary%20Volume%E2%80%90Outcome%20Analysis%20of%20UNOS&amp;author=O.%20M.%20Sharaf&amp;author=A.%20Bilgili&amp;author=Z.%20Brennan&amp;volume=118&amp;issue=6&amp;publication_year=2024&amp;pages=1288-1298&amp;pmid=38777247&amp;doi=10.1016/j.athoracsur.2024.05.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0030">
<span class="label">30.</span><cite>
Salonen R., Jahnukainen T., Nikkilä A., and Endén K., “Long‐Term Mortality in Pediatric Solid Organ Recipients‐A Nationwide Study,” Pediatric Transplantation
27, no. 2 (2023): e14463.
</cite> [<a href="https://doi.org/10.1111/petr.14463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36591862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Long%E2%80%90Term%20Mortality%20in%20Pediatric%20Solid%20Organ%20Recipients%E2%80%90A%20Nationwide%20Study&amp;author=R.%20Salonen&amp;author=T.%20Jahnukainen&amp;author=A.%20Nikkil%C3%A4&amp;author=K.%20End%C3%A9n&amp;volume=27&amp;issue=2&amp;publication_year=2023&amp;pages=e14463&amp;pmid=36591862&amp;doi=10.1111/petr.14463&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0031">
<span class="label">31.</span><cite>
Rosenthal L. M., Krauss A., Miera O., et al., “Changes in Waiting Time, Need for Mechanical Circulatory Support and Outcomes in Paediatric Heart Transplant Recipients,” ESC Heart Fail
11, no. 6 (2024): 3626–3635.
</cite> [<a href="https://doi.org/10.1002/ehf2.14917" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11631324/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39005003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESC%20Heart%20Fail&amp;title=Changes%20in%20Waiting%20Time,%20Need%20for%20Mechanical%20Circulatory%20Support%20and%20Outcomes%20in%20Paediatric%20Heart%20Transplant%20Recipients&amp;author=L.%20M.%20Rosenthal&amp;author=A.%20Krauss&amp;author=O.%20Miera&amp;volume=11&amp;issue=6&amp;publication_year=2024&amp;pages=3626-3635&amp;pmid=39005003&amp;doi=10.1002/ehf2.14917&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0032">
<span class="label">32.</span><cite>
Singh T. P., Hsich E., Cherikh W. S., et al., “The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung Transplantation,” Journal of Heart and Lung Transplantation
25 (2025): S1053–2498.</cite> [<a href="https://doi.org/10.1016/j.healun.2025.04.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40300677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=The%20International%20Thoracic%20Organ%20Transplant%20Registry%20of%20the%20International%20Society%20for%20Heart%20and%20Lung%20Transplantation:%202025%20Annual%20Report%20of%20Heart%20and%20Lung%20Transplantation&amp;author=T.%20P.%20Singh&amp;author=E.%20Hsich&amp;author=W.%20S.%20Cherikh&amp;volume=25&amp;publication_year=2025&amp;pages=S1053-2498&amp;pmid=40300677&amp;doi=10.1016/j.healun.2025.04.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0033">
<span class="label">33.</span><cite>
van der Have O., Tran‐Lundmark K., Wåhlander H., et al., “Pediatric Heart Transplantation Within the Scandiatransplant Region ‐ A Multinational Observational Study Spanning 38 Years,” Journal of Heart and Lung Transplantation (2025).</cite> [<a href="https://doi.org/10.1016/j.healun.2025.05.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40482845/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Pediatric%20Heart%20Transplantation%20Within%20the%20Scandiatransplant%20Region%20%E2%80%90%20A%20Multinational%20Observational%20Study%20Spanning%2038%E2%80%89Years&amp;author=O.%20van%20der%20Have&amp;author=K.%20Tran%E2%80%90Lundmark&amp;author=H.%20W%C3%A5hlander&amp;publication_year=2025&amp;pmid=40482845&amp;doi=10.1016/j.healun.2025.05.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0034">
<span class="label">34.</span><cite>
Richmond M. E., Conway J., Kirklin J. K., et al., “Three Decades of Collaboration Through the Pediatric Heart Transplant Society Registry: A Journey Through Registry Data With a Highlight on Children With Single Ventricle Anatomy,” Pediatric Transplantation
28 (2024): e14615.
</cite> [<a href="https://doi.org/10.1111/petr.14615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37811686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Three%20Decades%20of%20Collaboration%20Through%20the%20Pediatric%20Heart%20Transplant%20Society%20Registry:%20A%20Journey%20Through%20Registry%20Data%20With%20a%20Highlight%20on%20Children%20With%20Single%20Ventricle%20Anatomy&amp;author=M.%20E.%20Richmond&amp;author=J.%20Conway&amp;author=J.%20K.%20Kirklin&amp;volume=28&amp;publication_year=2024&amp;pages=e14615&amp;pmid=37811686&amp;doi=10.1111/petr.14615&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0035">
<span class="label">35.</span><cite>
Dipchand A. I., Kirk R., Edwards L. B., et al., “The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report—2013; Focus Theme: Age,” Journal of Heart and Lung Transplantation
32, no. 10 (2013): 979–988.</cite> [<a href="https://doi.org/10.1016/j.healun.2013.08.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24054806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=The%20Registry%20of%20the%20International%20Society%20for%20Heart%20and%20Lung%20Transplantation:%20Sixteenth%20Official%20Pediatric%20Heart%20Transplantation%20Report%E2%80%942013;%20Focus%20Theme:%20Age&amp;author=A.%20I.%20Dipchand&amp;author=R.%20Kirk&amp;author=L.%20B.%20Edwards&amp;volume=32&amp;issue=10&amp;publication_year=2013&amp;pages=979-988&amp;pmid=24054806&amp;doi=10.1016/j.healun.2013.08.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0036">
<span class="label">36.</span><cite>
Blume E. D., Naftel D. C., Bastardi H. J., Duncan B. W., Kirklin J. K., and Webber S. A., “Outcomes of Children Bridged to Heart Transplantation With Ventricular Assist Devices ‐ A Multi‐Institutional Study,” Circulation
113, no. 19 (2006): 2313–2319.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.105.577601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16702487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Outcomes%20of%20Children%20Bridged%20to%20Heart%20Transplantation%20With%20Ventricular%20Assist%20Devices%20%E2%80%90%20A%20Multi%E2%80%90Institutional%20Study&amp;author=E.%20D.%20Blume&amp;author=D.%20C.%20Naftel&amp;author=H.%20J.%20Bastardi&amp;author=B.%20W.%20Duncan&amp;author=J.%20K.%20Kirklin&amp;volume=113&amp;issue=19&amp;publication_year=2006&amp;pages=2313-2319&amp;pmid=16702487&amp;doi=10.1161/CIRCULATIONAHA.105.577601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0037">
<span class="label">37.</span><cite>
Davies R. R., Haldeman S., McCulloch M. A., and Pizarro C., “Ventricular Assist Devices as a Bridge‐To‐Transplant Improve Early Post‐Transplant Outcomes in Children,” Journal of Heart and Lung Transplantation
33, no. 7 (2014): 704–712.</cite> [<a href="https://doi.org/10.1016/j.healun.2014.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24709269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Ventricular%20Assist%20Devices%20as%20a%20Bridge%E2%80%90To%E2%80%90Transplant%20Improve%20Early%20Post%E2%80%90Transplant%20Outcomes%20in%20Children&amp;author=R.%20R.%20Davies&amp;author=S.%20Haldeman&amp;author=M.%20A.%20McCulloch&amp;author=C.%20Pizarro&amp;volume=33&amp;issue=7&amp;publication_year=2014&amp;pages=704-712&amp;pmid=24709269&amp;doi=10.1016/j.healun.2014.02.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0038">
<span class="label">38.</span><cite>
Dipchand A. I., Mahle W. T., Tresler M., et al., “Extracorporeal Membrane Oxygenation as a Bridge to Pediatric Heart Transplantation: Effect on Post‐Listing and Post‐Transplantation Outcomes,” Circulation. Heart Failure
8 (2015): 960–969.
</cite> [<a href="https://doi.org/10.1161/CIRCHEARTFAILURE.114.001553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26206854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation.%20Heart%20Failure&amp;title=Extracorporeal%20Membrane%20Oxygenation%20as%20a%20Bridge%20to%20Pediatric%20Heart%20Transplantation:%20Effect%20on%20Post%E2%80%90Listing%20and%20Post%E2%80%90Transplantation%20Outcomes&amp;author=A.%20I.%20Dipchand&amp;author=W.%20T.%20Mahle&amp;author=M.%20Tresler&amp;volume=8&amp;publication_year=2015&amp;pages=960-969&amp;pmid=26206854&amp;doi=10.1161/CIRCHEARTFAILURE.114.001553&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0039">
<span class="label">39.</span><cite>
Simmonds J., Zangwill S. D., Wisotzkey B., et al., “Mechanical Circulatory Support Early After Pediatric Heart Transplantation‐An Analysis From the Pediatric Heart Transplant Society,” Journal of Heart and Lung Transplantation
44, no. 2 (2025): 227–233.</cite> [<a href="https://doi.org/10.1016/j.healun.2024.09.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39270993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Mechanical%20Circulatory%20Support%20Early%20After%20Pediatric%20Heart%20Transplantation%E2%80%90An%20Analysis%20From%20the%20Pediatric%20Heart%20Transplant%20Society&amp;author=J.%20Simmonds&amp;author=S.%20D.%20Zangwill&amp;author=B.%20Wisotzkey&amp;volume=44&amp;issue=2&amp;publication_year=2025&amp;pages=227-233&amp;pmid=39270993&amp;doi=10.1016/j.healun.2024.09.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0040">
<span class="label">40.</span><cite>
Alsoufi B., Kozik D., Lambert A. N., et al., “Associated Factors and Impact of Persistent Renal Dysfunction in Pediatric Heart Transplantation,” Annals of Thoracic Surgery
117, no. 1 (2024): 136–142.
</cite> [<a href="https://doi.org/10.1016/j.athoracsur.2023.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36634833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Thoracic%20Surgery&amp;title=Associated%20Factors%20and%20Impact%20of%20Persistent%20Renal%20Dysfunction%20in%20Pediatric%20Heart%20Transplantation&amp;author=B.%20Alsoufi&amp;author=D.%20Kozik&amp;author=A.%20N.%20Lambert&amp;volume=117&amp;issue=1&amp;publication_year=2024&amp;pages=136-142&amp;pmid=36634833&amp;doi=10.1016/j.athoracsur.2023.01.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0041">
<span class="label">41.</span><cite>
Grimm K., Lehner A., Fernandez Rodriguez S., et al., “Conversion to Everolimus in Pediatric Heart Transplant Recipients Is a Safe Treatment Option With an Impact on Cardiac Allograft Vasculopathy and Renal Function,” Clinical Transplantation
35, no. 3 (2021): e14191.
</cite> [<a href="https://doi.org/10.1111/ctr.14191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33315277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Transplantation&amp;title=Conversion%20to%20Everolimus%20in%20Pediatric%20Heart%20Transplant%20Recipients%20Is%20a%20Safe%20Treatment%20Option%20With%20an%20Impact%20on%20Cardiac%20Allograft%20Vasculopathy%20and%20Renal%20Function&amp;author=K.%20Grimm&amp;author=A.%20Lehner&amp;author=S.%20Fernandez%20Rodriguez&amp;volume=35&amp;issue=3&amp;publication_year=2021&amp;pages=e14191&amp;pmid=33315277&amp;doi=10.1111/ctr.14191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0042">
<span class="label">42.</span><cite>
Rosenthal L. M., Nordmeyer J., Kramer P., et al., “Long‐Term Experience Using CNI‐Free Immunosuppression in Selected Paediatric Heart Transplant Recipients,” Pediatric Transplantation
25, no. 8 (2021): e14111.
</cite> [<a href="https://doi.org/10.1111/petr.14111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34405495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Transplantation&amp;title=Long%E2%80%90Term%20Experience%20Using%20CNI%E2%80%90Free%20Immunosuppression%20in%20Selected%20Paediatric%20Heart%20Transplant%20Recipients&amp;author=L.%20M.%20Rosenthal&amp;author=J.%20Nordmeyer&amp;author=P.%20Kramer&amp;volume=25&amp;issue=8&amp;publication_year=2021&amp;pages=e14111&amp;pmid=34405495&amp;doi=10.1111/petr.14111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0043">
<span class="label">43.</span><cite>
Richmond M. E., Law Y. M., Das B. B., et al., “Elevated Pre‐Transplant Pulmonary Vascular Resistance Is Not Associated With Mortality in Children Without Congenital Heart Disease: A Multicenter Study,” Journal of Heart and Lung Transplantation
34, no. 3 (2015): 448–456.</cite> [<a href="https://doi.org/10.1016/j.healun.2014.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24906793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=Elevated%20Pre%E2%80%90Transplant%20Pulmonary%20Vascular%20Resistance%20Is%20Not%20Associated%20With%20Mortality%20in%20Children%20Without%20Congenital%20Heart%20Disease:%20A%20Multicenter%20Study&amp;author=M.%20E.%20Richmond&amp;author=Y.%20M.%20Law&amp;author=B.%20B.%20Das&amp;volume=34&amp;issue=3&amp;publication_year=2015&amp;pages=448-456&amp;pmid=24906793&amp;doi=10.1016/j.healun.2014.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0044">
<span class="label">44.</span><cite>
Piccinelli E., Grutter G., Pilati M., et al., “Use of the CardioMEMS Device in Children and Patients With Congenital Heart Disease: A Literature Review,” Journal of Clinical Medicine
13, no. 14 (2024): 4234.
</cite> [<a href="https://doi.org/10.3390/jcm13144234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11277830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39064274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Medicine&amp;title=Use%20of%20the%20CardioMEMS%20Device%20in%20Children%20and%20Patients%20With%20Congenital%20Heart%20Disease:%20A%20Literature%20Review&amp;author=E.%20Piccinelli&amp;author=G.%20Grutter&amp;author=M.%20Pilati&amp;volume=13&amp;issue=14&amp;publication_year=2024&amp;pages=4234&amp;pmid=39064274&amp;doi=10.3390/jcm13144234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0045">
<span class="label">45.</span><cite>
Long Z., Yokota R., Peng L., Kaufman B., Chen S., and Kwiatkowski D., “PEDS11: Use of the CardioMEMSTM HF System in Pediatric Patients for Heart Failure Management,” ASAIO Journal
69, no. Supplement 2 (2023): 83.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=ASAIO%20Journal&amp;title=PEDS11:%20Use%20of%20the%20CardioMEMSTM%20HF%20System%20in%20Pediatric%20Patients%20for%20Heart%20Failure%20Management&amp;author=Z.%20Long&amp;author=R.%20Yokota&amp;author=L.%20Peng&amp;author=B.%20Kaufman&amp;author=S.%20Chen&amp;volume=69&amp;issue=Supplement%202&amp;publication_year=2023&amp;pages=83&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0046">
<span class="label">46.</span><cite>
Amdani S., Deshpande S. R., Liu W., and Urschel S., “Impact of the Pediatric ABO Policy Change on Listings, Transplants, and Outcomes for Children Younger Than 2 Years Listed for Heart Transplantation in the United States,” Journal of Cardiac Failure
30, no. 3 (2024): 476–485.
</cite> [<a href="https://doi.org/10.1016/j.cardfail.2023.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37328049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cardiac%20Failure&amp;title=Impact%20of%20the%20Pediatric%20ABO%20Policy%20Change%20on%20Listings,%20Transplants,%20and%20Outcomes%20for%20Children%20Younger%20Than%202%E2%80%89Years%20Listed%20for%20Heart%20Transplantation%20in%20the%20United%20States&amp;author=S.%20Amdani&amp;author=S.%20R.%20Deshpande&amp;author=W.%20Liu&amp;author=S.%20Urschel&amp;volume=30&amp;issue=3&amp;publication_year=2024&amp;pages=476-485&amp;pmid=37328049&amp;doi=10.1016/j.cardfail.2023.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0047">
<span class="label">47.</span><cite>
Bansal N., West L. J., Simmonds J., and Urschel S., “ABO‐Incompatible Heart Transplantation‐Evolution of a Revolution,” Journal of Heart and Lung Transplantation
43, no. 9 (2024): 1514–1520.</cite> [<a href="https://doi.org/10.1016/j.healun.2024.03.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38604353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Heart%20and%20Lung%20Transplantation&amp;title=ABO%E2%80%90Incompatible%20Heart%20Transplantation%E2%80%90Evolution%20of%20a%20Revolution&amp;author=N.%20Bansal&amp;author=L.%20J.%20West&amp;author=J.%20Simmonds&amp;author=S.%20Urschel&amp;volume=43&amp;issue=9&amp;publication_year=2024&amp;pages=1514-1520&amp;pmid=38604353&amp;doi=10.1016/j.healun.2024.03.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0048">
<span class="label">48.</span><cite>
Lefaucheur C., Louis K., Morris A. B., et al., “Clinical Recommendations for Posttransplant Assessment of Anti‐HLA (Human Leukocyte Antigen) Donor‐Specific Antibodies: A Sensitization in Transplantation: Assessment of Risk Consensus Document,” American Journal of Transplantation
23, no. 1 (2023): 115–132.
</cite> [<a href="https://doi.org/10.1016/j.ajt.2022.11.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36695614/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Transplantation&amp;title=Clinical%20Recommendations%20for%20Posttransplant%20Assessment%20of%20Anti%E2%80%90HLA%20(Human%20Leukocyte%20Antigen)%20Donor%E2%80%90Specific%20Antibodies:%20A%20Sensitization%20in%20Transplantation:%20Assessment%20of%20Risk%20Consensus%20Document&amp;author=C.%20Lefaucheur&amp;author=K.%20Louis&amp;author=A.%20B.%20Morris&amp;volume=23&amp;issue=1&amp;publication_year=2023&amp;pages=115-132&amp;pmid=36695614&amp;doi=10.1016/j.ajt.2022.11.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="petr70154-bib-0049">
<span class="label">49.</span><cite>
Loupy A., Coutance G., Bonnet G., et al., “Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population‐Based Study,” Circulation
141 (2020): 1954–1967.
</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.119.044924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32363949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Identification%20and%20Characterization%20of%20Trajectories%20of%20Cardiac%20Allograft%20Vasculopathy%20After%20Heart%20Transplantation:%20A%20Population%E2%80%90Based%20Study&amp;author=A.%20Loupy&amp;author=G.%20Coutance&amp;author=G.%20Bonnet&amp;volume=141&amp;publication_year=2020&amp;pages=1954-1967&amp;pmid=32363949&amp;doi=10.1161/CIRCULATIONAHA.119.044924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358703/bin/PETR-29-e70154-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">PETR-29-e70154-s001.docx</a><sup> (293.7KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Pediatric Transplantation are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/petr.70154"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/PETR-29-e70154.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12358703/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12358703/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12358703%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358703/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12358703/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12358703/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40820386/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12358703/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40820386/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12358703/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12358703/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="IDrDVyXccfPfuDMUoXNVPy13cRe79HkGRJzGLHeh5GR58t4tGInWL5KgbI7vDqEy">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
